pairID
stringlengths
36
36
gold_label
stringclasses
3 values
sentence1
stringlengths
7
1.07k
sentence2
stringlengths
7
110
sentence1_parse
stringlengths
33
2.87k
sentence2_parse
stringlengths
22
290
sentence1_binary_parse
stringlengths
15
1.99k
sentence2_binary_parse
stringlengths
6
187
23eb94b8-66c7-11e7-a8dc-f45c89b91419
entailment
Labs were notable for Cr 1.7 (baseline 0.5 per old records) and lactate 2.4.
Patient has elevated Cr
(ROOT (S (NP (NNPS Labs)) (VP (VBD were) (ADJP (JJ notable) (PP (IN for) (NP (NP (NP (NN Cr) (CD 1.7)) (PRN (-LRB- -LRB-) (NP (NP (NN baseline) (CD 0.5)) (PP (IN per) (NP (JJ old) (NNS records)))) (-RRB- -RRB-))) (CC and) (NP (NN lactate) (CD 2.4)))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ elevated) (NN Cr)))))
( Labs ( ( were ( notable ( for ( ( ( ( Cr 1.7 ) ( -LRB- ( ( ( baseline 0.5 ) ( per ( old records ) ) ) -RRB- ) ) ) and ) ( lactate 2.4 ) ) ) ) ) . ) )
( Patient ( has ( elevated Cr ) ) )
23eb979c-66c7-11e7-b76c-f45c89b91419
contradiction
Labs were notable for Cr 1.7 (baseline 0.5 per old records) and lactate 2.4.
Patient has normal Cr
(ROOT (S (NP (NNPS Labs)) (VP (VBD were) (ADJP (JJ notable) (PP (IN for) (NP (NP (NP (NN Cr) (CD 1.7)) (PRN (-LRB- -LRB-) (NP (NP (NN baseline) (CD 0.5)) (PP (IN per) (NP (JJ old) (NNS records)))) (-RRB- -RRB-))) (CC and) (NP (NN lactate) (CD 2.4)))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ normal) (NN Cr)))))
( Labs ( ( were ( notable ( for ( ( ( ( Cr 1.7 ) ( -LRB- ( ( ( baseline 0.5 ) ( per ( old records ) ) ) -RRB- ) ) ) and ) ( lactate 2.4 ) ) ) ) ) . ) )
( Patient ( has ( normal Cr ) ) )
23eb9986-66c7-11e7-9ef9-f45c89b91419
neutral
Labs were notable for Cr 1.7 (baseline 0.5 per old records) and lactate 2.4.
Patient has elevated BUN
(ROOT (S (NP (NNPS Labs)) (VP (VBD were) (ADJP (JJ notable) (PP (IN for) (NP (NP (NP (NN Cr) (CD 1.7)) (PRN (-LRB- -LRB-) (NP (NP (NN baseline) (CD 0.5)) (PP (IN per) (NP (JJ old) (NNS records)))) (-RRB- -RRB-))) (CC and) (NP (NN lactate) (CD 2.4)))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ elevated) (NN BUN)))))
( Labs ( ( were ( notable ( for ( ( ( ( Cr 1.7 ) ( -LRB- ( ( ( baseline 0.5 ) ( per ( old records ) ) ) -RRB- ) ) ) and ) ( lactate 2.4 ) ) ) ) ) . ) )
( Patient ( has ( elevated BUN ) ) )
23eb9ba2-66c7-11e7-9ac1-f45c89b91419
entailment
Nystagmus and twiching of R arm was noted.
The patient had abnormal neuro exam.
(ROOT (S (NP (NP (NNP Nystagmus)) (CC and) (NP (NP (NN twiching)) (PP (IN of) (NP (NN R) (NN arm))))) (VP (VBD was) (VP (VBN noted))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (JJ abnormal) (NN neuro) (NN exam))) (. .)))
( ( ( Nystagmus and ) ( twiching ( of ( R arm ) ) ) ) ( ( was noted ) . ) )
( ( The patient ) ( ( had ( abnormal ( neuro exam ) ) ) . ) )
23eb9d64-66c7-11e7-a16b-f45c89b91419
contradiction
Nystagmus and twiching of R arm was noted.
The patient has a normal neuro exam.
(ROOT (S (NP (NP (NNP Nystagmus)) (CC and) (NP (NP (NN twiching)) (PP (IN of) (NP (NN R) (NN arm))))) (VP (VBD was) (VP (VBN noted))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ normal) (NN neuro) (NN exam))) (. .)))
( ( ( Nystagmus and ) ( twiching ( of ( R arm ) ) ) ) ( ( was noted ) . ) )
( ( The patient ) ( ( has ( a ( normal ( neuro exam ) ) ) ) . ) )
23eb9f12-66c7-11e7-8d5d-f45c89b91419
neutral
Nystagmus and twiching of R arm was noted.
The patient has an acute stroke.
(ROOT (S (NP (NP (NNP Nystagmus)) (CC and) (NP (NP (NN twiching)) (PP (IN of) (NP (NN R) (NN arm))))) (VP (VBD was) (VP (VBN noted))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT an) (JJ acute) (NN stroke))) (. .)))
( ( ( Nystagmus and ) ( twiching ( of ( R arm ) ) ) ) ( ( was noted ) . ) )
( ( The patient ) ( ( has ( an ( acute stroke ) ) ) . ) )
23eba108-66c7-11e7-a551-f45c89b91419
entailment
The patient was seen by his primary care physician after he had complained of a one-week history of dyspnea on exertion and jaw tightness.
The patient has symptoms of a CHF exacerbation.
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN seen) (PP (IN by) (NP (PRP$ his) (JJ primary) (NN care) (NN physician))) (SBAR (IN after) (S (NP (PRP he)) (VP (VBD had) (VP (VBN complained) (PP (IN of) (NP (NP (DT a) (JJ one-week) (NN history)) (PP (IN of) (NP (NN dyspnea))))) (PP (IN on) (NP (NN exertion) (CC and) (NN jaw) (NN tightness))))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (NNS symptoms)) (PP (IN of) (NP (DT a) (NN CHF) (NN exacerbation))))) (. .)))
( ( The patient ) ( ( was ( ( seen ( by ( his ( primary ( care physician ) ) ) ) ) ( after ( he ( had ( ( complained ( of ( ( a ( one-week history ) ) ( of dyspnea ) ) ) ) ( on ( exertion ( and ( jaw tightness ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( ( has ( symptoms ( of ( a ( CHF exacerbation ) ) ) ) ) . ) )
23eba310-66c7-11e7-8840-f45c89b91419
contradiction
The patient was seen by his primary care physician after he had complained of a one-week history of dyspnea on exertion and jaw tightness.
The patient has no symptoms.
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN seen) (PP (IN by) (NP (PRP$ his) (JJ primary) (NN care) (NN physician))) (SBAR (IN after) (S (NP (PRP he)) (VP (VBD had) (VP (VBN complained) (PP (IN of) (NP (NP (DT a) (JJ one-week) (NN history)) (PP (IN of) (NP (NN dyspnea))))) (PP (IN on) (NP (NN exertion) (CC and) (NN jaw) (NN tightness))))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT no) (NNS symptoms))) (. .)))
( ( The patient ) ( ( was ( ( seen ( by ( his ( primary ( care physician ) ) ) ) ) ( after ( he ( had ( ( complained ( of ( ( a ( one-week history ) ) ( of dyspnea ) ) ) ) ( on ( exertion ( and ( jaw tightness ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( ( has ( no symptoms ) ) . ) )
23eba502-66c7-11e7-a947-f45c89b91419
neutral
The patient was seen by his primary care physician after he had complained of a one-week history of dyspnea on exertion and jaw tightness.
The patient has has coronary artery disease.
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN seen) (PP (IN by) (NP (PRP$ his) (JJ primary) (NN care) (NN physician))) (SBAR (IN after) (S (NP (PRP he)) (VP (VBD had) (VP (VBN complained) (PP (IN of) (NP (NP (DT a) (JJ one-week) (NN history)) (PP (IN of) (NP (NN dyspnea))))) (PP (IN on) (NP (NN exertion) (CC and) (NN jaw) (NN tightness))))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (VP (VBZ has) (NP (JJ coronary) (NN artery) (NN disease)))) (. .)))
( ( The patient ) ( ( was ( ( seen ( by ( his ( primary ( care physician ) ) ) ) ) ( after ( he ( had ( ( complained ( of ( ( a ( one-week history ) ) ( of dyspnea ) ) ) ) ( on ( exertion ( and ( jaw tightness ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( ( has ( has ( coronary ( artery disease ) ) ) ) . ) )
23eba750-66c7-11e7-a9bc-f45c89b91419
entailment
At [**Hospital 1456**] Hospital the patient was experiencing 10 out of 10 chest pain and received nitropaste two inches, three sublingual nitroglycerins, morphine 4 mg intravenously, Lopressor 5 mg intravenously.
The patient is being treated with medications used to treat acute coronary syndrome.
(ROOT (SBAR (IN At) (S (-LRB- -LSB-) (X (SYM **)) (NP (NNP Hospital) (CD 1456)) (X (SYM **)) (NP (-RRB- -RSB-) (NNP Hospital) (DT the) (NN patient)) (VP (VP (VBD was) (VP (VBG experiencing) (NP (CD 10)) (PP (IN out) (PP (IN of) (NP (CD 10) (NN chest) (NN pain)))))) (CC and) (VP (VBD received) (NP (NP (JJ nitropaste) (CD two) (NNS inches)) (, ,) (NP (NP (CD three) (JJ sublingual) (NNS nitroglycerins)) (, ,) (NP (NP (NN morphine) (CD 4) (NN mg)) (ADVP (RB intravenously)))) (, ,) (NP (NP (NNP Lopressor) (CD 5) (NN mg)) (ADVP (RB intravenously))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (NNS medications)) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (JJ acute) (JJ coronary) (NN syndrome))))))))))) (. .)))
( ( At ( -LSB- ( ** ( ( Hospital 1456 ) ( ** ( ( -RSB- ( Hospital ( the patient ) ) ) ( ( ( was ( ( experiencing 10 ) ( out ( of ( 10 ( chest pain ) ) ) ) ) ) and ) ( received ( ( ( ( ( nitropaste ( two inches ) ) , ) ( ( ( three ( sublingual nitroglycerins ) ) , ) ( ( morphine ( 4 mg ) ) intravenously ) ) ) , ) ( ( Lopressor ( 5 mg ) ) intravenously ) ) ) ) ) ) ) ) ) ) . )
( ( The patient ) ( ( is ( being ( treated ( with ( medications ( used ( to ( treat ( acute ( coronary syndrome ) ) ) ) ) ) ) ) ) ) . ) )
23ebb1d2-66c7-11e7-b462-f45c89b91419
contradiction
At [**Hospital 1456**] Hospital the patient was experiencing 10 out of 10 chest pain and received nitropaste two inches, three sublingual nitroglycerins, morphine 4 mg intravenously, Lopressor 5 mg intravenously.
The patient is asymptomatic.
(ROOT (SBAR (IN At) (S (-LRB- -LSB-) (X (SYM **)) (NP (NNP Hospital) (CD 1456)) (X (SYM **)) (NP (-RRB- -RSB-) (NNP Hospital) (DT the) (NN patient)) (VP (VP (VBD was) (VP (VBG experiencing) (NP (CD 10)) (PP (IN out) (PP (IN of) (NP (CD 10) (NN chest) (NN pain)))))) (CC and) (VP (VBD received) (NP (NP (JJ nitropaste) (CD two) (NNS inches)) (, ,) (NP (NP (CD three) (JJ sublingual) (NNS nitroglycerins)) (, ,) (NP (NP (NN morphine) (CD 4) (NN mg)) (ADVP (RB intravenously)))) (, ,) (NP (NP (NNP Lopressor) (CD 5) (NN mg)) (ADVP (RB intravenously))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (ADJP (JJ asymptomatic))) (. .)))
( ( At ( -LSB- ( ** ( ( Hospital 1456 ) ( ** ( ( -RSB- ( Hospital ( the patient ) ) ) ( ( ( was ( ( experiencing 10 ) ( out ( of ( 10 ( chest pain ) ) ) ) ) ) and ) ( received ( ( ( ( ( nitropaste ( two inches ) ) , ) ( ( ( three ( sublingual nitroglycerins ) ) , ) ( ( morphine ( 4 mg ) ) intravenously ) ) ) , ) ( ( Lopressor ( 5 mg ) ) intravenously ) ) ) ) ) ) ) ) ) ) . )
( ( The patient ) ( ( is asymptomatic ) . ) )
23ebb678-66c7-11e7-9479-f45c89b91419
neutral
At [**Hospital 1456**] Hospital the patient was experiencing 10 out of 10 chest pain and received nitropaste two inches, three sublingual nitroglycerins, morphine 4 mg intravenously, Lopressor 5 mg intravenously.
The patient is having a myocardial infarction.
(ROOT (SBAR (IN At) (S (-LRB- -LSB-) (X (SYM **)) (NP (NNP Hospital) (CD 1456)) (X (SYM **)) (NP (-RRB- -RSB-) (NNP Hospital) (DT the) (NN patient)) (VP (VP (VBD was) (VP (VBG experiencing) (NP (CD 10)) (PP (IN out) (PP (IN of) (NP (CD 10) (NN chest) (NN pain)))))) (CC and) (VP (VBD received) (NP (NP (JJ nitropaste) (CD two) (NNS inches)) (, ,) (NP (NP (CD three) (JJ sublingual) (NNS nitroglycerins)) (, ,) (NP (NP (NN morphine) (CD 4) (NN mg)) (ADVP (RB intravenously)))) (, ,) (NP (NP (NNP Lopressor) (CD 5) (NN mg)) (ADVP (RB intravenously))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (VP (VBG having) (NP (DT a) (JJ myocardial) (NN infarction)))) (. .)))
( ( At ( -LSB- ( ** ( ( Hospital 1456 ) ( ** ( ( -RSB- ( Hospital ( the patient ) ) ) ( ( ( was ( ( experiencing 10 ) ( out ( of ( 10 ( chest pain ) ) ) ) ) ) and ) ( received ( ( ( ( ( nitropaste ( two inches ) ) , ) ( ( ( three ( sublingual nitroglycerins ) ) , ) ( ( morphine ( 4 mg ) ) intravenously ) ) ) , ) ( ( Lopressor ( 5 mg ) ) intravenously ) ) ) ) ) ) ) ) ) ) . )
( ( The patient ) ( ( is ( having ( a ( myocardial infarction ) ) ) ) . ) )
23ebb8be-66c7-11e7-9b6c-f45c89b91419
entailment
History of nephrolithiasis with hematuria 5.
patient has a history of kidney stones
(ROOT (NP (NP (NP (NN History)) (PP (IN of) (NP (NN nephrolithiasis))) (PP (IN with) (NP (NN hematuria) (CD 5)))) (. .)))
(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN kidney) (NNS stones)))))))
( ( ( History ( of nephrolithiasis ) ) ( with ( hematuria 5 ) ) ) . )
( patient ( has ( ( a history ) ( of ( kidney stones ) ) ) ) )
23ebba88-66c7-11e7-9b5a-f45c89b91419
contradiction
History of nephrolithiasis with hematuria 5.
patient has no history of kidney stones
(ROOT (NP (NP (NP (NN History)) (PP (IN of) (NP (NN nephrolithiasis))) (PP (IN with) (NP (NN hematuria) (CD 5)))) (. .)))
(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (NN kidney) (NNS stones)))))))
( ( ( History ( of nephrolithiasis ) ) ( with ( hematuria 5 ) ) ) . )
( patient ( has ( ( no history ) ( of ( kidney stones ) ) ) ) )
23ebbc2c-66c7-11e7-a4d6-f45c89b91419
neutral
History of nephrolithiasis with hematuria 5.
patient has flank pain
(ROOT (NP (NP (NP (NN History)) (PP (IN of) (NP (NN nephrolithiasis))) (PP (IN with) (NP (NN hematuria) (CD 5)))) (. .)))
(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (JJ flank) (NN pain)))))
( ( ( History ( of nephrolithiasis ) ) ( with ( hematuria 5 ) ) ) . )
( patient ( has ( flank pain ) ) )
23ebbdf8-66c7-11e7-a17b-f45c89b91419
entailment
Per patient, he took a combined 100+ pills of Lisinopril, Nifedipine, and Atenolol late yesterday evening.
The patient overdosed on medication.
(ROOT (S (PP (IN Per) (NP (NN patient))) (, ,) (NP (PRP he)) (VP (VP (VBD took) (NP (DT a) (JJ combined) (CD 100) (CC +) (NP (NP (NNS pills)) (PP (IN of) (NP (NP (NNP Lisinopril)) (, ,) (NP (NNP Nifedipine)) (, ,)))))) (CC and) (NP (NNP Atenolol) (JJ late) (NN yesterday) (NN evening))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD overdosed) (PP (IN on) (NP (NN medication)))) (. .)))
( ( Per patient ) ( , ( he ( ( ( ( took ( a ( combined ( ( 100 + ) ( pills ( of ( ( ( Lisinopril , ) Nifedipine ) , ) ) ) ) ) ) ) and ) ( Atenolol ( late ( yesterday evening ) ) ) ) . ) ) ) )
( ( The patient ) ( ( overdosed ( on medication ) ) . ) )
23ebbfd8-66c7-11e7-adbd-f45c89b91419
contradiction
Per patient, he took a combined 100+ pills of Lisinopril, Nifedipine, and Atenolol late yesterday evening.
The patient did not take extra medication.
(ROOT (S (PP (IN Per) (NP (NN patient))) (, ,) (NP (PRP he)) (VP (VP (VBD took) (NP (DT a) (JJ combined) (CD 100) (CC +) (NP (NP (NNS pills)) (PP (IN of) (NP (NP (NNP Lisinopril)) (, ,) (NP (NNP Nifedipine)) (, ,)))))) (CC and) (NP (NNP Atenolol) (JJ late) (NN yesterday) (NN evening))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD did) (RB not) (VP (VB take) (NP (JJ extra) (NN medication)))) (. .)))
( ( Per patient ) ( , ( he ( ( ( ( took ( a ( combined ( ( 100 + ) ( pills ( of ( ( ( Lisinopril , ) Nifedipine ) , ) ) ) ) ) ) ) and ) ( Atenolol ( late ( yesterday evening ) ) ) ) . ) ) ) )
( ( The patient ) ( ( ( did not ) ( take ( extra medication ) ) ) . ) )
23ebc336-66c7-11e7-a59f-f45c89b91419
neutral
Per patient, he took a combined 100+ pills of Lisinopril, Nifedipine, and Atenolol late yesterday evening.
The patient is depressed.
(ROOT (S (PP (IN Per) (NP (NN patient))) (, ,) (NP (PRP he)) (VP (VP (VBD took) (NP (DT a) (JJ combined) (CD 100) (CC +) (NP (NP (NNS pills)) (PP (IN of) (NP (NP (NNP Lisinopril)) (, ,) (NP (NNP Nifedipine)) (, ,)))))) (CC and) (NP (NNP Atenolol) (JJ late) (NN yesterday) (NN evening))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (ADJP (VBN depressed))) (. .)))
( ( Per patient ) ( , ( he ( ( ( ( took ( a ( combined ( ( 100 + ) ( pills ( of ( ( ( Lisinopril , ) Nifedipine ) , ) ) ) ) ) ) ) and ) ( Atenolol ( late ( yesterday evening ) ) ) ) . ) ) ) )
( ( The patient ) ( ( is depressed ) . ) )
23ebc564-66c7-11e7-bbdc-f45c89b91419
entailment
Temporary pacing wire was placed on [**11-7**] for persistent complete heart block, but per report the patient was not pacer dependent.
The patient has a heart condition
(ROOT (S (NP (JJ Temporary) (NN pacing) (NN wire)) (VP (VBD was) (VP (VBN placed) (PP (IN on) (S (-LRB- -LSB-) (SYM **) (CD 11-7) (X (SYM **)) (WHNP (-RRB- -RSB-) (PP (IN for) (NP (JJ persistent) (JJ complete) (NN heart) (NN block)))) (, ,) (CC but) (PP (IN per) (NP (NN report))) (NP (DT the) (NN patient)) (VP (VBD was) (RB not) (ADJP (NN pacer) (JJ dependent))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (NN heart) (NN condition)))))
( ( Temporary ( pacing wire ) ) ( ( was ( placed ( on ( -LSB- ( ** ( 11-7 ( ** ( ( -RSB- ( for ( persistent ( complete ( heart block ) ) ) ) ) ( , ( but ( ( per report ) ( ( the patient ) ( ( was not ) ( pacer dependent ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( has ( a ( heart condition ) ) ) )
23ebc818-66c7-11e7-906c-f45c89b91419
contradiction
Temporary pacing wire was placed on [**11-7**] for persistent complete heart block, but per report the patient was not pacer dependent.
The patient has normal cardiac function
(ROOT (S (NP (JJ Temporary) (NN pacing) (NN wire)) (VP (VBD was) (VP (VBN placed) (PP (IN on) (S (-LRB- -LSB-) (SYM **) (CD 11-7) (X (SYM **)) (WHNP (-RRB- -RSB-) (PP (IN for) (NP (JJ persistent) (JJ complete) (NN heart) (NN block)))) (, ,) (CC but) (PP (IN per) (NP (NN report))) (NP (DT the) (NN patient)) (VP (VBD was) (RB not) (ADJP (NN pacer) (JJ dependent))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ normal) (JJ cardiac) (NN function)))))
( ( Temporary ( pacing wire ) ) ( ( was ( placed ( on ( -LSB- ( ** ( 11-7 ( ** ( ( -RSB- ( for ( persistent ( complete ( heart block ) ) ) ) ) ( , ( but ( ( per report ) ( ( the patient ) ( ( was not ) ( pacer dependent ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( has ( normal ( cardiac function ) ) ) )
23ebca1e-66c7-11e7-bc0b-f45c89b91419
neutral
Temporary pacing wire was placed on [**11-7**] for persistent complete heart block, but per report the patient was not pacer dependent.
The patient has a history of hypertension
(ROOT (S (NP (JJ Temporary) (NN pacing) (NN wire)) (VP (VBD was) (VP (VBN placed) (PP (IN on) (S (-LRB- -LSB-) (SYM **) (CD 11-7) (X (SYM **)) (WHNP (-RRB- -RSB-) (PP (IN for) (NP (JJ persistent) (JJ complete) (NN heart) (NN block)))) (, ,) (CC but) (PP (IN per) (NP (NN report))) (NP (DT the) (NN patient)) (VP (VBD was) (RB not) (ADJP (NN pacer) (JJ dependent))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN hypertension)))))))
( ( Temporary ( pacing wire ) ) ( ( was ( placed ( on ( -LSB- ( ** ( 11-7 ( ** ( ( -RSB- ( for ( persistent ( complete ( heart block ) ) ) ) ) ( , ( but ( ( per report ) ( ( the patient ) ( ( was not ) ( pacer dependent ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( has ( ( a history ) ( of hypertension ) ) ) )
23ebcc3a-66c7-11e7-b179-f45c89b91419
entailment
On [**8-19**], he did finally have his cardiac catheterization which showed no flow limiting coronary artery disease but he did have an ascending aortic aneurysm of approximately six cm.
Cardiac catheterization revealed no blockage
(ROOT (SBAR (IN On) (S (-LRB- -LSB-) (NP (SYM **) (CD 8-19) (X (SYM **)) (-RRB- -RSB-)) (, ,) (NP (PRP he)) (VP (VBD did) (ADVP (RB finally)) (VP (VB have) (NP (NP (PRP$ his) (JJ cardiac) (NN catheterization)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBD showed) (S (NP (DT no) (NN flow)) (VP (VBG limiting) (NP (JJ coronary) (NN artery) (NN disease))))) (CC but) (SBAR (S (NP (PRP he)) (VP (VBD did) (VP (VB have) (NP (DT an) (S (VP (VBG ascending) (NP (NP (JJ aortic) (NN aneurysm)) (PP (IN of) (NP (QP (RB approximately) (CD six)) (NN cm)))))))))))))))))) (. .)))
(ROOT (S (NP (JJ Cardiac) (NN catheterization)) (VP (VBD revealed) (NP (DT no) (NN blockage)))))
( ( On ( -LSB- ( ( ** ( ( 8-19 ** ) -RSB- ) ) ( , ( he ( ( did finally ) ( have ( ( his ( cardiac catheterization ) ) ( which ( ( ( showed ( ( no flow ) ( limiting ( coronary ( artery disease ) ) ) ) ) but ) ( he ( did ( have ( an ( ascending ( ( aortic aneurysm ) ( of ( ( approximately six ) cm ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )
( ( Cardiac catheterization ) ( revealed ( no blockage ) ) )
23ebce54-66c7-11e7-abac-f45c89b91419
contradiction
On [**8-19**], he did finally have his cardiac catheterization which showed no flow limiting coronary artery disease but he did have an ascending aortic aneurysm of approximately six cm.
Cardiac catheterization revealed flow limiting blockage
(ROOT (SBAR (IN On) (S (-LRB- -LSB-) (NP (SYM **) (CD 8-19) (X (SYM **)) (-RRB- -RSB-)) (, ,) (NP (PRP he)) (VP (VBD did) (ADVP (RB finally)) (VP (VB have) (NP (NP (PRP$ his) (JJ cardiac) (NN catheterization)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBD showed) (S (NP (DT no) (NN flow)) (VP (VBG limiting) (NP (JJ coronary) (NN artery) (NN disease))))) (CC but) (SBAR (S (NP (PRP he)) (VP (VBD did) (VP (VB have) (NP (DT an) (S (VP (VBG ascending) (NP (NP (JJ aortic) (NN aneurysm)) (PP (IN of) (NP (QP (RB approximately) (CD six)) (NN cm)))))))))))))))))) (. .)))
(ROOT (S (NP (JJ Cardiac) (NN catheterization)) (VP (VBD revealed) (NP (NN flow) (VBG limiting) (NN blockage)))))
( ( On ( -LSB- ( ( ** ( ( 8-19 ** ) -RSB- ) ) ( , ( he ( ( did finally ) ( have ( ( his ( cardiac catheterization ) ) ( which ( ( ( showed ( ( no flow ) ( limiting ( coronary ( artery disease ) ) ) ) ) but ) ( he ( did ( have ( an ( ascending ( ( aortic aneurysm ) ( of ( ( approximately six ) cm ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )
( ( Cardiac catheterization ) ( revealed ( flow ( limiting blockage ) ) ) )
23ebd07e-66c7-11e7-8b73-f45c89b91419
neutral
On [**8-19**], he did finally have his cardiac catheterization which showed no flow limiting coronary artery disease but he did have an ascending aortic aneurysm of approximately six cm.
The patient has a history of hypertension and smoking
(ROOT (SBAR (IN On) (S (-LRB- -LSB-) (NP (SYM **) (CD 8-19) (X (SYM **)) (-RRB- -RSB-)) (, ,) (NP (PRP he)) (VP (VBD did) (ADVP (RB finally)) (VP (VB have) (NP (NP (PRP$ his) (JJ cardiac) (NN catheterization)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBD showed) (S (NP (DT no) (NN flow)) (VP (VBG limiting) (NP (JJ coronary) (NN artery) (NN disease))))) (CC but) (SBAR (S (NP (PRP he)) (VP (VBD did) (VP (VB have) (NP (DT an) (S (VP (VBG ascending) (NP (NP (JJ aortic) (NN aneurysm)) (PP (IN of) (NP (QP (RB approximately) (CD six)) (NN cm)))))))))))))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (NN hypertension)) (CC and) (NN smoking)))))))
( ( On ( -LSB- ( ( ** ( ( 8-19 ** ) -RSB- ) ) ( , ( he ( ( did finally ) ( have ( ( his ( cardiac catheterization ) ) ( which ( ( ( showed ( ( no flow ) ( limiting ( coronary ( artery disease ) ) ) ) ) but ) ( he ( did ( have ( an ( ascending ( ( aortic aneurysm ) ( of ( ( approximately six ) cm ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . )
( ( The patient ) ( has ( ( a history ) ( of ( ( hypertension and ) smoking ) ) ) ) )
23ebd37e-66c7-11e7-aec4-f45c89b91419
entailment
At [**Hospital **] rehab, he was being treated with vanco/flagyl for suspected aspiration pneumonia.
The patient has suspected aspiration pneumonia
(ROOT (PP (IN At) (S (-LRB- -LSB-) (FRAG (NP (SYM **) (NNP Hospital) (X (SYM **)) (-RRB- -RSB-) (NN rehab))) (, ,) (NP (PRP he)) (VP (VBD was) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN vanco/flagyl))) (PP (IN for) (NP (VBN suspected) (NN aspiration) (NN pneumonia))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (VP (VBN suspected) (NP (NN aspiration) (NN pneumonia))))))
( ( At ( -LSB- ( ( ** ( Hospital ( ** ( -RSB- rehab ) ) ) ) ( , ( he ( was ( being ( ( treated ( with vanco/flagyl ) ) ( for ( suspected ( aspiration pneumonia ) ) ) ) ) ) ) ) ) ) ) . )
( ( The patient ) ( has ( suspected ( aspiration pneumonia ) ) ) )
23ebd57e-66c7-11e7-b938-f45c89b91419
contradiction
At [**Hospital **] rehab, he was being treated with vanco/flagyl for suspected aspiration pneumonia.
the patient is not on antibiotics
(ROOT (PP (IN At) (S (-LRB- -LSB-) (FRAG (NP (SYM **) (NNP Hospital) (X (SYM **)) (-RRB- -RSB-) (NN rehab))) (, ,) (NP (PRP he)) (VP (VBD was) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN vanco/flagyl))) (PP (IN for) (NP (VBN suspected) (NN aspiration) (NN pneumonia))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ is) (RB not) (PP (IN on) (NP (NNS antibiotics))))))
( ( At ( -LSB- ( ( ** ( Hospital ( ** ( -RSB- rehab ) ) ) ) ( , ( he ( was ( being ( ( treated ( with vanco/flagyl ) ) ( for ( suspected ( aspiration pneumonia ) ) ) ) ) ) ) ) ) ) ) . )
( ( the patient ) ( ( is not ) ( on antibiotics ) ) )
23ebd73e-66c7-11e7-8193-f45c89b91419
neutral
At [**Hospital **] rehab, he was being treated with vanco/flagyl for suspected aspiration pneumonia.
the patient had a stroke
(ROOT (PP (IN At) (S (-LRB- -LSB-) (FRAG (NP (SYM **) (NNP Hospital) (X (SYM **)) (-RRB- -RSB-) (NN rehab))) (, ,) (NP (PRP he)) (VP (VBD was) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN vanco/flagyl))) (PP (IN for) (NP (VBN suspected) (NN aspiration) (NN pneumonia))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBD had) (NP (DT a) (NN stroke)))))
( ( At ( -LSB- ( ( ** ( Hospital ( ** ( -RSB- rehab ) ) ) ) ( , ( he ( was ( being ( ( treated ( with vanco/flagyl ) ) ( for ( suspected ( aspiration pneumonia ) ) ) ) ) ) ) ) ) ) ) . )
( ( the patient ) ( had ( a stroke ) ) )
23ebd8cc-66c7-11e7-9b01-f45c89b91419
entailment
AROM at delivery yielded clear amniotic fluid.
Patient has delivered a baby
(ROOT (S (NP (NP (NN AROM)) (PP (IN at) (NP (NN delivery)))) (VP (VBD yielded) (NP (JJ clear) (JJ amniotic) (NN fluid))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN delivered) (NP (DT a) (NN baby))))))
( ( AROM ( at delivery ) ) ( ( yielded ( clear ( amniotic fluid ) ) ) . ) )
( Patient ( has ( delivered ( a baby ) ) ) )
23ebdafe-66c7-11e7-8629-f45c89b91419
contradiction
AROM at delivery yielded clear amniotic fluid.
Patient has not been pregnant
(ROOT (S (NP (NP (NN AROM)) (PP (IN at) (NP (NN delivery)))) (VP (VBD yielded) (NP (JJ clear) (JJ amniotic) (NN fluid))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (RB not) (VP (VBN been) (ADJP (JJ pregnant))))))
( ( AROM ( at delivery ) ) ( ( yielded ( clear ( amniotic fluid ) ) ) . ) )
( Patient ( ( has not ) ( been pregnant ) ) )
23ebdca2-66c7-11e7-a286-f45c89b91419
neutral
AROM at delivery yielded clear amniotic fluid.
Patient has no PMH
(ROOT (S (NP (NP (NN AROM)) (PP (IN at) (NP (NN delivery)))) (VP (VBD yielded) (NP (JJ clear) (JJ amniotic) (NN fluid))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (NN PMH)))))
( ( AROM ( at delivery ) ) ( ( yielded ( clear ( amniotic fluid ) ) ) . ) )
( Patient ( has ( no PMH ) ) )
23ebde6e-66c7-11e7-a97c-f45c89b91419
entailment
Left dominant, mild left main, 50% left anterior descending and minimal luminal irregularities.
There is 50% blockage in the left anterior descending coronary artery
(ROOT (S (VP (VBN Left) (S (ADJP (ADJP (JJ dominant)) (, ,) (ADJP (JJ mild)))) (VP (VBD left) (ADJP (JJ main))) (, ,) (NP (NP (CD 50) (NN %)) (VP (VBD left) (NP (JJ anterior) (VBG descending) (CC and) (JJ minimal) (JJ luminal) (NNS irregularities))))) (. .)))
(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (ADJP (CD 50) (NN %)) (NN blockage)) (PP (IN in) (NP (DT the) (JJ left) (JJ anterior) (VBG descending) (NP (JJ coronary) (NN artery))))))))
( ( ( ( ( Left ( ( dominant , ) mild ) ) ( left main ) ) , ) ( ( 50 % ) ( left ( anterior ( descending ( and ( minimal ( luminal irregularities ) ) ) ) ) ) ) ) . )
( There ( is ( ( ( 50 % ) blockage ) ( in ( the ( left ( anterior ( descending ( coronary artery ) ) ) ) ) ) ) ) )
23ebe03a-66c7-11e7-9bd6-f45c89b91419
contradiction
Left dominant, mild left main, 50% left anterior descending and minimal luminal irregularities.
There is no blockage in the coronary arteries
(ROOT (S (VP (VBN Left) (S (ADJP (ADJP (JJ dominant)) (, ,) (ADJP (JJ mild)))) (VP (VBD left) (ADJP (JJ main))) (, ,) (NP (NP (CD 50) (NN %)) (VP (VBD left) (NP (JJ anterior) (VBG descending) (CC and) (JJ minimal) (JJ luminal) (NNS irregularities))))) (. .)))
(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (NN blockage)) (PP (IN in) (NP (DT the) (JJ coronary) (NNS arteries)))))))
( ( ( ( ( Left ( ( dominant , ) mild ) ) ( left main ) ) , ) ( ( 50 % ) ( left ( anterior ( descending ( and ( minimal ( luminal irregularities ) ) ) ) ) ) ) ) . )
( There ( is ( ( no blockage ) ( in ( the ( coronary arteries ) ) ) ) ) )
23ebe206-66c7-11e7-b5c1-f45c89b91419
neutral
Left dominant, mild left main, 50% left anterior descending and minimal luminal irregularities.
The patient has a history of high cholesterol and high blood pressure
(ROOT (S (VP (VBN Left) (S (ADJP (ADJP (JJ dominant)) (, ,) (ADJP (JJ mild)))) (VP (VBD left) (ADJP (JJ main))) (, ,) (NP (NP (CD 50) (NN %)) (VP (VBD left) (NP (JJ anterior) (VBG descending) (CC and) (JJ minimal) (JJ luminal) (NNS irregularities))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ high) (NN cholesterol)) (CC and) (NP (JJ high) (NN blood) (NN pressure))))))))
( ( ( ( ( Left ( ( dominant , ) mild ) ) ( left main ) ) , ) ( ( 50 % ) ( left ( anterior ( descending ( and ( minimal ( luminal irregularities ) ) ) ) ) ) ) ) . )
( ( The patient ) ( has ( ( a history ) ( of ( ( ( high cholesterol ) and ) ( high ( blood pressure ) ) ) ) ) ) )
23ebe59e-66c7-11e7-ada4-f45c89b91419
entailment
The patient began having symptoms of abdominal pain, nausea and vomiting similar to [** Location **]us episodes of diverticulitis three weeks ago and about a week later presented to the [**Hospital3 **] when she noted stool draining from her vagina and a CT scan at the outside hospital documented the enterovaginal fistula.
She has a history of digestive disease
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD began) (S (VP (VBG having) (NP (NP (NNS symptoms)) (PP (IN of) (NP (JJ abdominal) (NN pain)))))) (, ,) (S (VP (NN nausea) (CC and) (VP (VBG vomiting) (ADJP (JJ similar) (PP (TO to) (S (-LRB- -LSB-) (SYM **) (NP (NNP Location)) (X (SYM **)) (-RRB- -RSB-) (NP (PRP us)) (UCP (NP (NP (NNS episodes)) (PP (IN of) (NP (NN diverticulitis)))) (ADVP (NP (CD three) (NNS weeks)) (RB ago)) (CC and)) (PP (IN about) (NP (DT a) (NN week))) (VP (ADVP (RB later)) (VBD presented) (PP (TO to) (NP (DT the) (S (-LRB- -LSB-) (SYM **) (NN Hospital3) (X (SYM **)) (-RRB- -RSB-) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD noted) (S (NP (NP (NP (NN stool) (VBG draining)) (PP (IN from) (NP (PRP$ her) (NN vagina)))) (CC and) (NP (DT a) (NN CT))) (VP (VB scan) (PP (IN at) (NP (DT the) (JJ outside) (NN hospital)))))))) (VP (VBD documented) (NP (DT the) (JJ enterovaginal) (NN fistula)))))))))))))) (. .)))
(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ digestive) (NN disease)))))))
( ( The patient ) ( ( ( ( began ( having ( symptoms ( of ( abdominal pain ) ) ) ) ) , ) ( ( nausea and ) ( vomiting ( similar ( to ( -LSB- ( ** ( Location ( ** ( -RSB- ( us ( ( ( episodes ( of diverticulitis ) ) ( ( ( three weeks ) ago ) and ) ) ( ( about ( a week ) ) ( later ( presented ( to ( the ( -LSB- ( ** ( Hospital3 ( ** ( -RSB- ( ( when ( she ( noted ( ( ( ( ( stool draining ) ( from ( her vagina ) ) ) and ) ( a CT ) ) ( scan ( at ( the ( outside hospital ) ) ) ) ) ) ) ) ( documented ( the ( enterovaginal fistula ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( She ( has ( ( a history ) ( of ( digestive disease ) ) ) ) )
23ebe864-66c7-11e7-ba69-f45c89b91419
contradiction
The patient began having symptoms of abdominal pain, nausea and vomiting similar to [** Location **]us episodes of diverticulitis three weeks ago and about a week later presented to the [**Hospital3 **] when she noted stool draining from her vagina and a CT scan at the outside hospital documented the enterovaginal fistula.
She has no gastrointestinal dysfunction
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD began) (S (VP (VBG having) (NP (NP (NNS symptoms)) (PP (IN of) (NP (JJ abdominal) (NN pain)))))) (, ,) (S (VP (NN nausea) (CC and) (VP (VBG vomiting) (ADJP (JJ similar) (PP (TO to) (S (-LRB- -LSB-) (SYM **) (NP (NNP Location)) (X (SYM **)) (-RRB- -RSB-) (NP (PRP us)) (UCP (NP (NP (NNS episodes)) (PP (IN of) (NP (NN diverticulitis)))) (ADVP (NP (CD three) (NNS weeks)) (RB ago)) (CC and)) (PP (IN about) (NP (DT a) (NN week))) (VP (ADVP (RB later)) (VBD presented) (PP (TO to) (NP (DT the) (S (-LRB- -LSB-) (SYM **) (NN Hospital3) (X (SYM **)) (-RRB- -RSB-) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD noted) (S (NP (NP (NP (NN stool) (VBG draining)) (PP (IN from) (NP (PRP$ her) (NN vagina)))) (CC and) (NP (DT a) (NN CT))) (VP (VB scan) (PP (IN at) (NP (DT the) (JJ outside) (NN hospital)))))))) (VP (VBD documented) (NP (DT the) (JJ enterovaginal) (NN fistula)))))))))))))) (. .)))
(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (DT no) (JJ gastrointestinal) (NN dysfunction)))))
( ( The patient ) ( ( ( ( began ( having ( symptoms ( of ( abdominal pain ) ) ) ) ) , ) ( ( nausea and ) ( vomiting ( similar ( to ( -LSB- ( ** ( Location ( ** ( -RSB- ( us ( ( ( episodes ( of diverticulitis ) ) ( ( ( three weeks ) ago ) and ) ) ( ( about ( a week ) ) ( later ( presented ( to ( the ( -LSB- ( ** ( Hospital3 ( ** ( -RSB- ( ( when ( she ( noted ( ( ( ( ( stool draining ) ( from ( her vagina ) ) ) and ) ( a CT ) ) ( scan ( at ( the ( outside hospital ) ) ) ) ) ) ) ) ( documented ( the ( enterovaginal fistula ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( She ( has ( no ( gastrointestinal dysfunction ) ) ) )
23ebeee2-66c7-11e7-b1d3-f45c89b91419
neutral
The patient began having symptoms of abdominal pain, nausea and vomiting similar to [** Location **]us episodes of diverticulitis three weeks ago and about a week later presented to the [**Hospital3 **] when she noted stool draining from her vagina and a CT scan at the outside hospital documented the enterovaginal fistula.
She has a history of obesity
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD began) (S (VP (VBG having) (NP (NP (NNS symptoms)) (PP (IN of) (NP (JJ abdominal) (NN pain)))))) (, ,) (S (VP (NN nausea) (CC and) (VP (VBG vomiting) (ADJP (JJ similar) (PP (TO to) (S (-LRB- -LSB-) (SYM **) (NP (NNP Location)) (X (SYM **)) (-RRB- -RSB-) (NP (PRP us)) (UCP (NP (NP (NNS episodes)) (PP (IN of) (NP (NN diverticulitis)))) (ADVP (NP (CD three) (NNS weeks)) (RB ago)) (CC and)) (PP (IN about) (NP (DT a) (NN week))) (VP (ADVP (RB later)) (VBD presented) (PP (TO to) (NP (DT the) (S (-LRB- -LSB-) (SYM **) (NN Hospital3) (X (SYM **)) (-RRB- -RSB-) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD noted) (S (NP (NP (NP (NN stool) (VBG draining)) (PP (IN from) (NP (PRP$ her) (NN vagina)))) (CC and) (NP (DT a) (NN CT))) (VP (VB scan) (PP (IN at) (NP (DT the) (JJ outside) (NN hospital)))))))) (VP (VBD documented) (NP (DT the) (JJ enterovaginal) (NN fistula)))))))))))))) (. .)))
(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN obesity)))))))
( ( The patient ) ( ( ( ( began ( having ( symptoms ( of ( abdominal pain ) ) ) ) ) , ) ( ( nausea and ) ( vomiting ( similar ( to ( -LSB- ( ** ( Location ( ** ( -RSB- ( us ( ( ( episodes ( of diverticulitis ) ) ( ( ( three weeks ) ago ) and ) ) ( ( about ( a week ) ) ( later ( presented ( to ( the ( -LSB- ( ** ( Hospital3 ( ** ( -RSB- ( ( when ( she ( noted ( ( ( ( ( stool draining ) ( from ( her vagina ) ) ) and ) ( a CT ) ) ( scan ( at ( the ( outside hospital ) ) ) ) ) ) ) ) ( documented ( the ( enterovaginal fistula ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( She ( has ( ( a history ) ( of obesity ) ) ) )
23ebf0d4-66c7-11e7-b5de-f45c89b91419
entailment
She was started on Dilantin.
The patient has pain.
(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NNP Dilantin))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NN pain))) (. .)))
( She ( ( was ( started ( on Dilantin ) ) ) . ) )
( ( The patient ) ( ( has pain ) . ) )
23ebf264-66c7-11e7-805b-f45c89b91419
contradiction
She was started on Dilantin.
The patient has no pain issues.
(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NNP Dilantin))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT no) (NN pain) (NNS issues))) (. .)))
( She ( ( was ( started ( on Dilantin ) ) ) . ) )
( ( The patient ) ( ( has ( no ( pain issues ) ) ) . ) )
23ebf4f8-66c7-11e7-92a1-f45c89b91419
neutral
She was started on Dilantin.
The patient is hospitalized
(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NNP Dilantin))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (VP (VBN hospitalized)))))
( She ( ( was ( started ( on Dilantin ) ) ) . ) )
( ( The patient ) ( is hospitalized ) )
23ebf70a-66c7-11e7-b74a-f45c89b91419
entailment
[**Known patient firstname **] [**Known patient lastname 6979**] is a 54-year-old woman with history of CNS lymphoma who presents with increasing seizures and hypotension.
the patient has CNS lymphoma
(ROOT (PRN (PRN (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (JJ firstname) (SYM **)) (-RRB- -RSB-)) (SINV (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (JJ lastname) (CD 6979)) (X (SYM **)) (SINV (ADJP (-RRB- -RSB-)) (VP (VBZ is)) (NP (NP (DT a) (JJ 54-year-old) (NN woman)) (PP (IN with) (NP (NP (NN history)) (PP (IN of) (NP (NN CNS) (NN lymphoma))))) (SBAR (WHNP (WP who)) (S (VP (VBZ presents) (PP (IN with) (S (VP (VBG increasing) (NP (NNS seizures) (CC and) (NN hypotension))))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NN CNS) (NN lymphoma)))))
( ( -LSB- ( ( ** ( Known ( ( patient firstname ) ** ) ) ) -RSB- ) ) ( ( -LSB- ( ( ** ( Known ( ( patient lastname ) 6979 ) ) ) ( ** ( -RSB- ( is ( ( ( a ( 54-year-old woman ) ) ( with ( history ( of ( CNS lymphoma ) ) ) ) ) ( who ( presents ( with ( increasing ( ( seizures and ) hypotension ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( the patient ) ( has ( CNS lymphoma ) ) )
23ebf926-66c7-11e7-98b6-f45c89b91419
contradiction
[**Known patient firstname **] [**Known patient lastname 6979**] is a 54-year-old woman with history of CNS lymphoma who presents with increasing seizures and hypotension.
the patient has no neurologic symptoms
(ROOT (PRN (PRN (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (JJ firstname) (SYM **)) (-RRB- -RSB-)) (SINV (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (JJ lastname) (CD 6979)) (X (SYM **)) (SINV (ADJP (-RRB- -RSB-)) (VP (VBZ is)) (NP (NP (DT a) (JJ 54-year-old) (NN woman)) (PP (IN with) (NP (NP (NN history)) (PP (IN of) (NP (NN CNS) (NN lymphoma))))) (SBAR (WHNP (WP who)) (S (VP (VBZ presents) (PP (IN with) (S (VP (VBG increasing) (NP (NNS seizures) (CC and) (NN hypotension))))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (DT no) (JJ neurologic) (NNS symptoms)))))
( ( -LSB- ( ( ** ( Known ( ( patient firstname ) ** ) ) ) -RSB- ) ) ( ( -LSB- ( ( ** ( Known ( ( patient lastname ) 6979 ) ) ) ( ** ( -RSB- ( is ( ( ( a ( 54-year-old woman ) ) ( with ( history ( of ( CNS lymphoma ) ) ) ) ) ( who ( presents ( with ( increasing ( ( seizures and ) hypotension ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( the patient ) ( has ( no ( neurologic symptoms ) ) ) )
23ebfb24-66c7-11e7-8b6d-f45c89b91419
neutral
[**Known patient firstname **] [**Known patient lastname 6979**] is a 54-year-old woman with history of CNS lymphoma who presents with increasing seizures and hypotension.
the patient has HIV
(ROOT (PRN (PRN (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (JJ firstname) (SYM **)) (-RRB- -RSB-)) (SINV (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (JJ lastname) (CD 6979)) (X (SYM **)) (SINV (ADJP (-RRB- -RSB-)) (VP (VBZ is)) (NP (NP (DT a) (JJ 54-year-old) (NN woman)) (PP (IN with) (NP (NP (NN history)) (PP (IN of) (NP (NN CNS) (NN lymphoma))))) (SBAR (WHNP (WP who)) (S (VP (VBZ presents) (PP (IN with) (S (VP (VBG increasing) (NP (NNS seizures) (CC and) (NN hypotension))))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NN HIV)))))
( ( -LSB- ( ( ** ( Known ( ( patient firstname ) ** ) ) ) -RSB- ) ) ( ( -LSB- ( ( ** ( Known ( ( patient lastname ) 6979 ) ) ) ( ** ( -RSB- ( is ( ( ( a ( 54-year-old woman ) ) ( with ( history ( of ( CNS lymphoma ) ) ) ) ) ( who ( presents ( with ( increasing ( ( seizures and ) hypotension ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( the patient ) ( has HIV ) )
23ebfcfa-66c7-11e7-b7da-f45c89b91419
entailment
At that time, he characterized his pain as chest tightening and burning, with associated radiation to his neck, jaw and arms.
He has chest pain
(ROOT (S (PP (IN At) (NP (DT that) (NN time))) (, ,) (NP (PRP he)) (VP (VBD characterized) (NP (PRP$ his) (NN pain)) (PP (IN as) (NP (NP (NN chest) (NN tightening)) (CC and) (NP (NN burning)))) (, ,) (NP (PP (IN with) (NP (NP (VBN associated) (NN radiation)) (PP (TO to) (NP (PRP$ his) (NN neck))))) (, ,) (NN jaw) (CC and) (NNS arms))) (. .)))
(ROOT (S (NP (PRP He)) (VP (VBZ has) (NP (NN chest) (NN pain)))))
( ( At ( that time ) ) ( , ( he ( ( ( ( ( characterized ( his pain ) ) ( as ( ( ( chest tightening ) and ) burning ) ) ) , ) ( ( with ( ( associated radiation ) ( to ( his neck ) ) ) ) ( , ( ( jaw and ) arms ) ) ) ) . ) ) ) )
( He ( has ( chest pain ) ) )
23ebfec6-66c7-11e7-bfe8-f45c89b91419
contradiction
At that time, he characterized his pain as chest tightening and burning, with associated radiation to his neck, jaw and arms.
He denies pain
(ROOT (S (PP (IN At) (NP (DT that) (NN time))) (, ,) (NP (PRP he)) (VP (VBD characterized) (NP (PRP$ his) (NN pain)) (PP (IN as) (NP (NP (NN chest) (NN tightening)) (CC and) (NP (NN burning)))) (, ,) (NP (PP (IN with) (NP (NP (VBN associated) (NN radiation)) (PP (TO to) (NP (PRP$ his) (NN neck))))) (, ,) (NN jaw) (CC and) (NNS arms))) (. .)))
(ROOT (S (NP (PRP He)) (VP (VBZ denies) (NP (NN pain)))))
( ( At ( that time ) ) ( , ( he ( ( ( ( ( characterized ( his pain ) ) ( as ( ( ( chest tightening ) and ) burning ) ) ) , ) ( ( with ( ( associated radiation ) ( to ( his neck ) ) ) ) ( , ( ( jaw and ) arms ) ) ) ) . ) ) ) )
( He ( denies pain ) )
23ec019e-66c7-11e7-9f7f-f45c89b91419
neutral
At that time, he characterized his pain as chest tightening and burning, with associated radiation to his neck, jaw and arms.
He has a history of coronary artery disease and hypertension
(ROOT (S (PP (IN At) (NP (DT that) (NN time))) (, ,) (NP (PRP he)) (VP (VBD characterized) (NP (PRP$ his) (NN pain)) (PP (IN as) (NP (NP (NN chest) (NN tightening)) (CC and) (NP (NN burning)))) (, ,) (NP (PP (IN with) (NP (NP (VBN associated) (NN radiation)) (PP (TO to) (NP (PRP$ his) (NN neck))))) (, ,) (NN jaw) (CC and) (NNS arms))) (. .)))
(ROOT (S (NP (PRP He)) (VP (VBZ has) (NP (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ coronary) (NN artery) (NN disease)))) (CC and) (NP (NN hypertension))))))
( ( At ( that time ) ) ( , ( he ( ( ( ( ( characterized ( his pain ) ) ( as ( ( ( chest tightening ) and ) burning ) ) ) , ) ( ( with ( ( associated radiation ) ( to ( his neck ) ) ) ) ( , ( ( jaw and ) arms ) ) ) ) . ) ) ) )
( He ( has ( ( ( ( a history ) ( of ( coronary ( artery disease ) ) ) ) and ) hypertension ) ) )
23ec05ba-66c7-11e7-ace6-f45c89b91419
entailment
Metastatic Renal Cell Carcinoma - diagnosed in [**4-/3406**] - s/p left radical nephrectomy [**5-13**] with pathology consistent with clear cell carcinoma - s/p right upper lobe wedge resection for pulmonary metastasis [**9-14**] - right frontal lobe brain metastasis s/p resection [**4-15**] with sterotactic radiosurgery to resection site [**5-16**] - s/p high dose IL-2 [**11-15**] - s/p right bilobectomy (right upper and right middle lobe) [**1-16**] - s/p right chest wall resection [**11-17**] - s/p right lower lobe wedge resection [**4-18**] - T8 s/p cyberknife [**11-18**] - s/p sunitinib [**8-18**] complicated by hand foot syndrome, mucositis - RAD001 trial [**1-18**] to present - s/p T8 and T9 vetebrectomy and recontruction [**3413-8-18**] Hypertension Peptic Ulcer Disease (h. pylori positive) Hyperglycemia
History of metastatic cancer
(ROOT (NP (NP (JJ Metastatic) (JJ Renal) (NN Cell) (NN Carcinoma)) (: -) (VP (VBN diagnosed) (PP (IN in) (S (-LRB- -LSB-) (SYM **) (LS 4) (: -) (: /) (CD 3406) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p)) (VP (VBD left) (NP (NP (JJ radical) (NN nephrectomy)) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (CD 5-13) (X (SYM **)) (-RRB- -RSB-)) (PP (IN with) (NP (NP (NN pathology)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ clear) (NN cell) (NN carcinoma)) (: -) (NP (NP (NP (NN s/p) (NN right) (JJ upper) (NN lobe) (NN wedge) (NN resection)) (PP (IN for) (NP (JJ pulmonary) (NN metastasis)))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 9-14) (X (SYM **)) (-RRB- -RSB-)) (: -) (SINV (NP (JJ right) (JJ frontal) (NN lobe) (NN brain) (NN metastasis) (NN s/p) (NN resection)) (-LRB- -LSB-) (SYM **) (CD 4-15) (X (SYM **)) (-RRB- -RSB-) (PP (IN with) (NP (NP (JJ sterotactic) (NN radiosurgery)) (PP (TO to) (NP (NN resection) (NN site))))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 5-16) (X (SYM **)) (-RRB- -RSB-)) (: -) (NP (NP (NN s/p) (JJ high) (NN dose) (NN IL-2)) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 11-15) (X (SYM **)) (-RRB- -RSB-)) (: -) (NP (NP (NP (JJ s/p) (JJ right) (NN bilobectomy)) (PRN (-LRB- -LRB-) (NP (JJ right) (ADJP (ADJP (JJ upper)) (CC and) (ADJP (JJ right))) (JJ middle) (NN lobe)) (-RRB- -RRB-))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 1-16) (X (SYM **)) (-RRB- -RSB-)) (: -) (SINV (NP (JJ s/p) (JJ right) (NN chest) (NN wall) (NN resection)) (-LRB- -LSB-) (SYM **) (CD 11-17) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p)) (NP (ADJP (RB right) (JJR lower)) (NN lobe) (NN wedge) (NN resection)) (-LRB- -LSB-) (NP (SYM **) (CD 4-18) (X (SYM **)) (-RRB- -RSB-) (: -) (NN T8) (NN s/p) (NN cyberknife)) (-LRB- -LSB-) (SYM **) (CD 11-18) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p) (NN sunitinib)) (-LRB- -LSB-) (SYM **) (CD 8-18) (X (SYM **)) (-RRB- -RSB-) (VBN complicated) (IN by) (NP (NP (NN hand) (NN foot) (NN syndrome)) (, ,) (NP (NN mucositis)) (: -)) (NP (NN RAD001) (NN trial)) (-LRB- -LSB-) (SYM **) (QP (CD 1-18)) (X (SYM **)) (-RRB- -RSB-) (PP (TO to) (NP (NP (NP (JJ present) (: -) (NX (NX (NN s/p) (NN T8)) (CC and) (NX (NX (NN T9) (NN vetebrectomy)) (CC and) (NX (NX (NN recontruction)) (-LRB- -LSB-) (SYM **))))) (CD 3413-8-18) (X (SYM **)) (-RRB- -RSB-) (NN Hypertension) (JJ Peptic) (NN Ulcer) (NN Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN h.) (NN pylori) (JJ positive) (-RRB- -RRB-)) (NN Hyperglycemia))))))))))))))))))))))))))))))))
(ROOT (NP (NP (NN History)) (PP (IN of) (NP (JJ metastatic) (NN cancer)))))
( ( ( Metastatic ( Renal ( Cell Carcinoma ) ) ) - ) ( diagnosed ( in ( -LSB- ( ** ( 4 ( - ( / ( 3406 ( ** ( -RSB- ( - ( s/p ( left ( ( radical nephrectomy ) ( -LSB- ( ( ** ( ( 5-13 ** ) -RSB- ) ) ( with ( pathology ( consistent ( with ( ( ( clear ( cell carcinoma ) ) - ) ( ( ( s/p ( right ( upper ( lobe ( wedge resection ) ) ) ) ) ( for ( pulmonary metastasis ) ) ) ( -LSB- ( ( ( ** ( ( 9-14 ** ) -RSB- ) ) - ) ( ( ( ( ( ( ( ( right ( frontal ( lobe ( brain ( metastasis ( s/p resection ) ) ) ) ) ) -LSB- ) ** ) 4-15 ) ** ) -RSB- ) ( with ( ( sterotactic radiosurgery ) ( to ( resection site ) ) ) ) ) ( -LSB- ( ( ( ** ( ( 5-16 ** ) -RSB- ) ) - ) ( ( s/p ( high ( dose IL-2 ) ) ) ( -LSB- ( ( ( ** ( ( 11-15 ** ) -RSB- ) ) - ) ( ( ( s/p ( right bilobectomy ) ) ( -LRB- ( ( right ( ( ( upper and ) right ) ( middle lobe ) ) ) -RRB- ) ) ) ( -LSB- ( ( ( ** ( ( 1-16 ** ) -RSB- ) ) - ) ( ( s/p ( right ( chest ( wall resection ) ) ) ) ( -LSB- ( ** ( 11-17 ( ** ( -RSB- ( - ( s/p ( ( ( right lower ) ( lobe ( wedge resection ) ) ) ( -LSB- ( ( ** ( 4-18 ( ** ( -RSB- ( - ( T8 ( s/p cyberknife ) ) ) ) ) ) ) ( -LSB- ( ** ( 11-18 ( ** ( -RSB- ( - ( ( s/p sunitinib ) ( -LSB- ( ** ( 8-18 ( ** ( -RSB- ( ( ( ( ( ( ( ( ( complicated by ) ( ( ( ( hand ( foot syndrome ) ) , ) mucositis ) - ) ) ( RAD001 trial ) ) -LSB- ) ** ) 1-18 ) ** ) -RSB- ) ( to ( ( ( present ( - ( ( ( s/p T8 ) and ) ( ( ( T9 vetebrectomy ) and ) ( ( recontruction -LSB- ) ** ) ) ) ) ) ( 3413-8-18 ( ** ( -RSB- ( Hypertension ( Peptic ( Ulcer Disease ) ) ) ) ) ) ) ( -LRB- ( ( h. ( ( pylori positive ) -RRB- ) ) Hyperglycemia ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
( History ( of ( metastatic cancer ) ) )
23ec0cd8-66c7-11e7-8835-f45c89b91419
contradiction
Metastatic Renal Cell Carcinoma - diagnosed in [**4-/3406**] - s/p left radical nephrectomy [**5-13**] with pathology consistent with clear cell carcinoma - s/p right upper lobe wedge resection for pulmonary metastasis [**9-14**] - right frontal lobe brain metastasis s/p resection [**4-15**] with sterotactic radiosurgery to resection site [**5-16**] - s/p high dose IL-2 [**11-15**] - s/p right bilobectomy (right upper and right middle lobe) [**1-16**] - s/p right chest wall resection [**11-17**] - s/p right lower lobe wedge resection [**4-18**] - T8 s/p cyberknife [**11-18**] - s/p sunitinib [**8-18**] complicated by hand foot syndrome, mucositis - RAD001 trial [**1-18**] to present - s/p T8 and T9 vetebrectomy and recontruction [**3413-8-18**] Hypertension Peptic Ulcer Disease (h. pylori positive) Hyperglycemia
No surgical history
(ROOT (NP (NP (JJ Metastatic) (JJ Renal) (NN Cell) (NN Carcinoma)) (: -) (VP (VBN diagnosed) (PP (IN in) (S (-LRB- -LSB-) (SYM **) (LS 4) (: -) (: /) (CD 3406) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p)) (VP (VBD left) (NP (NP (JJ radical) (NN nephrectomy)) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (CD 5-13) (X (SYM **)) (-RRB- -RSB-)) (PP (IN with) (NP (NP (NN pathology)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ clear) (NN cell) (NN carcinoma)) (: -) (NP (NP (NP (NN s/p) (NN right) (JJ upper) (NN lobe) (NN wedge) (NN resection)) (PP (IN for) (NP (JJ pulmonary) (NN metastasis)))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 9-14) (X (SYM **)) (-RRB- -RSB-)) (: -) (SINV (NP (JJ right) (JJ frontal) (NN lobe) (NN brain) (NN metastasis) (NN s/p) (NN resection)) (-LRB- -LSB-) (SYM **) (CD 4-15) (X (SYM **)) (-RRB- -RSB-) (PP (IN with) (NP (NP (JJ sterotactic) (NN radiosurgery)) (PP (TO to) (NP (NN resection) (NN site))))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 5-16) (X (SYM **)) (-RRB- -RSB-)) (: -) (NP (NP (NN s/p) (JJ high) (NN dose) (NN IL-2)) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 11-15) (X (SYM **)) (-RRB- -RSB-)) (: -) (NP (NP (NP (JJ s/p) (JJ right) (NN bilobectomy)) (PRN (-LRB- -LRB-) (NP (JJ right) (ADJP (ADJP (JJ upper)) (CC and) (ADJP (JJ right))) (JJ middle) (NN lobe)) (-RRB- -RRB-))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 1-16) (X (SYM **)) (-RRB- -RSB-)) (: -) (SINV (NP (JJ s/p) (JJ right) (NN chest) (NN wall) (NN resection)) (-LRB- -LSB-) (SYM **) (CD 11-17) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p)) (NP (ADJP (RB right) (JJR lower)) (NN lobe) (NN wedge) (NN resection)) (-LRB- -LSB-) (NP (SYM **) (CD 4-18) (X (SYM **)) (-RRB- -RSB-) (: -) (NN T8) (NN s/p) (NN cyberknife)) (-LRB- -LSB-) (SYM **) (CD 11-18) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p) (NN sunitinib)) (-LRB- -LSB-) (SYM **) (CD 8-18) (X (SYM **)) (-RRB- -RSB-) (VBN complicated) (IN by) (NP (NP (NN hand) (NN foot) (NN syndrome)) (, ,) (NP (NN mucositis)) (: -)) (NP (NN RAD001) (NN trial)) (-LRB- -LSB-) (SYM **) (QP (CD 1-18)) (X (SYM **)) (-RRB- -RSB-) (PP (TO to) (NP (NP (NP (JJ present) (: -) (NX (NX (NN s/p) (NN T8)) (CC and) (NX (NX (NN T9) (NN vetebrectomy)) (CC and) (NX (NX (NN recontruction)) (-LRB- -LSB-) (SYM **))))) (CD 3413-8-18) (X (SYM **)) (-RRB- -RSB-) (NN Hypertension) (JJ Peptic) (NN Ulcer) (NN Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN h.) (NN pylori) (JJ positive) (-RRB- -RRB-)) (NN Hyperglycemia))))))))))))))))))))))))))))))))
(ROOT (NP (DT No) (JJ surgical) (NN history)))
( ( ( Metastatic ( Renal ( Cell Carcinoma ) ) ) - ) ( diagnosed ( in ( -LSB- ( ** ( 4 ( - ( / ( 3406 ( ** ( -RSB- ( - ( s/p ( left ( ( radical nephrectomy ) ( -LSB- ( ( ** ( ( 5-13 ** ) -RSB- ) ) ( with ( pathology ( consistent ( with ( ( ( clear ( cell carcinoma ) ) - ) ( ( ( s/p ( right ( upper ( lobe ( wedge resection ) ) ) ) ) ( for ( pulmonary metastasis ) ) ) ( -LSB- ( ( ( ** ( ( 9-14 ** ) -RSB- ) ) - ) ( ( ( ( ( ( ( ( right ( frontal ( lobe ( brain ( metastasis ( s/p resection ) ) ) ) ) ) -LSB- ) ** ) 4-15 ) ** ) -RSB- ) ( with ( ( sterotactic radiosurgery ) ( to ( resection site ) ) ) ) ) ( -LSB- ( ( ( ** ( ( 5-16 ** ) -RSB- ) ) - ) ( ( s/p ( high ( dose IL-2 ) ) ) ( -LSB- ( ( ( ** ( ( 11-15 ** ) -RSB- ) ) - ) ( ( ( s/p ( right bilobectomy ) ) ( -LRB- ( ( right ( ( ( upper and ) right ) ( middle lobe ) ) ) -RRB- ) ) ) ( -LSB- ( ( ( ** ( ( 1-16 ** ) -RSB- ) ) - ) ( ( s/p ( right ( chest ( wall resection ) ) ) ) ( -LSB- ( ** ( 11-17 ( ** ( -RSB- ( - ( s/p ( ( ( right lower ) ( lobe ( wedge resection ) ) ) ( -LSB- ( ( ** ( 4-18 ( ** ( -RSB- ( - ( T8 ( s/p cyberknife ) ) ) ) ) ) ) ( -LSB- ( ** ( 11-18 ( ** ( -RSB- ( - ( ( s/p sunitinib ) ( -LSB- ( ** ( 8-18 ( ** ( -RSB- ( ( ( ( ( ( ( ( ( complicated by ) ( ( ( ( hand ( foot syndrome ) ) , ) mucositis ) - ) ) ( RAD001 trial ) ) -LSB- ) ** ) 1-18 ) ** ) -RSB- ) ( to ( ( ( present ( - ( ( ( s/p T8 ) and ) ( ( ( T9 vetebrectomy ) and ) ( ( recontruction -LSB- ) ** ) ) ) ) ) ( 3413-8-18 ( ** ( -RSB- ( Hypertension ( Peptic ( Ulcer Disease ) ) ) ) ) ) ) ( -LRB- ( ( h. ( ( pylori positive ) -RRB- ) ) Hyperglycemia ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
( No ( surgical history ) )
23ec131e-66c7-11e7-b260-f45c89b91419
neutral
Metastatic Renal Cell Carcinoma - diagnosed in [**4-/3406**] - s/p left radical nephrectomy [**5-13**] with pathology consistent with clear cell carcinoma - s/p right upper lobe wedge resection for pulmonary metastasis [**9-14**] - right frontal lobe brain metastasis s/p resection [**4-15**] with sterotactic radiosurgery to resection site [**5-16**] - s/p high dose IL-2 [**11-15**] - s/p right bilobectomy (right upper and right middle lobe) [**1-16**] - s/p right chest wall resection [**11-17**] - s/p right lower lobe wedge resection [**4-18**] - T8 s/p cyberknife [**11-18**] - s/p sunitinib [**8-18**] complicated by hand foot syndrome, mucositis - RAD001 trial [**1-18**] to present - s/p T8 and T9 vetebrectomy and recontruction [**3413-8-18**] Hypertension Peptic Ulcer Disease (h. pylori positive) Hyperglycemia
History of hematuria and flank pain
(ROOT (NP (NP (JJ Metastatic) (JJ Renal) (NN Cell) (NN Carcinoma)) (: -) (VP (VBN diagnosed) (PP (IN in) (S (-LRB- -LSB-) (SYM **) (LS 4) (: -) (: /) (CD 3406) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p)) (VP (VBD left) (NP (NP (JJ radical) (NN nephrectomy)) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (CD 5-13) (X (SYM **)) (-RRB- -RSB-)) (PP (IN with) (NP (NP (NN pathology)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ clear) (NN cell) (NN carcinoma)) (: -) (NP (NP (NP (NN s/p) (NN right) (JJ upper) (NN lobe) (NN wedge) (NN resection)) (PP (IN for) (NP (JJ pulmonary) (NN metastasis)))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 9-14) (X (SYM **)) (-RRB- -RSB-)) (: -) (SINV (NP (JJ right) (JJ frontal) (NN lobe) (NN brain) (NN metastasis) (NN s/p) (NN resection)) (-LRB- -LSB-) (SYM **) (CD 4-15) (X (SYM **)) (-RRB- -RSB-) (PP (IN with) (NP (NP (JJ sterotactic) (NN radiosurgery)) (PP (TO to) (NP (NN resection) (NN site))))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 5-16) (X (SYM **)) (-RRB- -RSB-)) (: -) (NP (NP (NN s/p) (JJ high) (NN dose) (NN IL-2)) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 11-15) (X (SYM **)) (-RRB- -RSB-)) (: -) (NP (NP (NP (JJ s/p) (JJ right) (NN bilobectomy)) (PRN (-LRB- -LRB-) (NP (JJ right) (ADJP (ADJP (JJ upper)) (CC and) (ADJP (JJ right))) (JJ middle) (NN lobe)) (-RRB- -RRB-))) (FRAG (-LRB- -LSB-) (NP (NP (SYM **) (CD 1-16) (X (SYM **)) (-RRB- -RSB-)) (: -) (SINV (NP (JJ s/p) (JJ right) (NN chest) (NN wall) (NN resection)) (-LRB- -LSB-) (SYM **) (CD 11-17) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p)) (NP (ADJP (RB right) (JJR lower)) (NN lobe) (NN wedge) (NN resection)) (-LRB- -LSB-) (NP (SYM **) (CD 4-18) (X (SYM **)) (-RRB- -RSB-) (: -) (NN T8) (NN s/p) (NN cyberknife)) (-LRB- -LSB-) (SYM **) (CD 11-18) (X (SYM **)) (-RRB- -RSB-) (: -) (NP (NN s/p) (NN sunitinib)) (-LRB- -LSB-) (SYM **) (CD 8-18) (X (SYM **)) (-RRB- -RSB-) (VBN complicated) (IN by) (NP (NP (NN hand) (NN foot) (NN syndrome)) (, ,) (NP (NN mucositis)) (: -)) (NP (NN RAD001) (NN trial)) (-LRB- -LSB-) (SYM **) (QP (CD 1-18)) (X (SYM **)) (-RRB- -RSB-) (PP (TO to) (NP (NP (NP (JJ present) (: -) (NX (NX (NN s/p) (NN T8)) (CC and) (NX (NX (NN T9) (NN vetebrectomy)) (CC and) (NX (NX (NN recontruction)) (-LRB- -LSB-) (SYM **))))) (CD 3413-8-18) (X (SYM **)) (-RRB- -RSB-) (NN Hypertension) (JJ Peptic) (NN Ulcer) (NN Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN h.) (NN pylori) (JJ positive) (-RRB- -RRB-)) (NN Hyperglycemia))))))))))))))))))))))))))))))))
(ROOT (NP (NP (NN History)) (PP (IN of) (NP (NP (NN hematuria)) (CC and) (NP (NN flank) (NN pain))))))
( ( ( Metastatic ( Renal ( Cell Carcinoma ) ) ) - ) ( diagnosed ( in ( -LSB- ( ** ( 4 ( - ( / ( 3406 ( ** ( -RSB- ( - ( s/p ( left ( ( radical nephrectomy ) ( -LSB- ( ( ** ( ( 5-13 ** ) -RSB- ) ) ( with ( pathology ( consistent ( with ( ( ( clear ( cell carcinoma ) ) - ) ( ( ( s/p ( right ( upper ( lobe ( wedge resection ) ) ) ) ) ( for ( pulmonary metastasis ) ) ) ( -LSB- ( ( ( ** ( ( 9-14 ** ) -RSB- ) ) - ) ( ( ( ( ( ( ( ( right ( frontal ( lobe ( brain ( metastasis ( s/p resection ) ) ) ) ) ) -LSB- ) ** ) 4-15 ) ** ) -RSB- ) ( with ( ( sterotactic radiosurgery ) ( to ( resection site ) ) ) ) ) ( -LSB- ( ( ( ** ( ( 5-16 ** ) -RSB- ) ) - ) ( ( s/p ( high ( dose IL-2 ) ) ) ( -LSB- ( ( ( ** ( ( 11-15 ** ) -RSB- ) ) - ) ( ( ( s/p ( right bilobectomy ) ) ( -LRB- ( ( right ( ( ( upper and ) right ) ( middle lobe ) ) ) -RRB- ) ) ) ( -LSB- ( ( ( ** ( ( 1-16 ** ) -RSB- ) ) - ) ( ( s/p ( right ( chest ( wall resection ) ) ) ) ( -LSB- ( ** ( 11-17 ( ** ( -RSB- ( - ( s/p ( ( ( right lower ) ( lobe ( wedge resection ) ) ) ( -LSB- ( ( ** ( 4-18 ( ** ( -RSB- ( - ( T8 ( s/p cyberknife ) ) ) ) ) ) ) ( -LSB- ( ** ( 11-18 ( ** ( -RSB- ( - ( ( s/p sunitinib ) ( -LSB- ( ** ( 8-18 ( ** ( -RSB- ( ( ( ( ( ( ( ( ( complicated by ) ( ( ( ( hand ( foot syndrome ) ) , ) mucositis ) - ) ) ( RAD001 trial ) ) -LSB- ) ** ) 1-18 ) ** ) -RSB- ) ( to ( ( ( present ( - ( ( ( s/p T8 ) and ) ( ( ( T9 vetebrectomy ) and ) ( ( recontruction -LSB- ) ** ) ) ) ) ) ( 3413-8-18 ( ** ( -RSB- ( Hypertension ( Peptic ( Ulcer Disease ) ) ) ) ) ) ) ( -LRB- ( ( h. ( ( pylori positive ) -RRB- ) ) Hyperglycemia ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
( History ( of ( ( hematuria and ) ( flank pain ) ) ) )
23ec1708-66c7-11e7-a2ea-f45c89b91419
entailment
She had an MRI as part of her metastatic workup which revealed multiple brain metastases, the largest of which was 1.5cm.
Patient has cancer
(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (DT an) (NNP MRI)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (PRP$ her) (JJ metastatic) (NN workup)) (SBAR (WHNP (WDT which)) (S (VP (VBD revealed) (NP (NP (JJ multiple) (NN brain) (NNS metastases)) (, ,) (SBAR (WHNP (NP (DT the) (JJS largest)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBD was) (NP (CD 1.5) (NN cm)))))))))))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN cancer)))))
( She ( ( ( had ( an MRI ) ) ( as ( part ( of ( ( her ( metastatic workup ) ) ( which ( revealed ( ( ( multiple ( brain metastases ) ) , ) ( ( ( the largest ) ( of which ) ) ( was ( 1.5 cm ) ) ) ) ) ) ) ) ) ) ) . ) )
( Patient ( has cancer ) )
23ec1a1e-66c7-11e7-9066-f45c89b91419
contradiction
She had an MRI as part of her metastatic workup which revealed multiple brain metastases, the largest of which was 1.5cm.
Patient has no malignancy
(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (DT an) (NNP MRI)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (PRP$ her) (JJ metastatic) (NN workup)) (SBAR (WHNP (WDT which)) (S (VP (VBD revealed) (NP (NP (JJ multiple) (NN brain) (NNS metastases)) (, ,) (SBAR (WHNP (NP (DT the) (JJS largest)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBD was) (NP (CD 1.5) (NN cm)))))))))))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (NN malignancy)))))
( She ( ( ( had ( an MRI ) ) ( as ( part ( of ( ( her ( metastatic workup ) ) ( which ( revealed ( ( ( multiple ( brain metastases ) ) , ) ( ( ( the largest ) ( of which ) ) ( was ( 1.5 cm ) ) ) ) ) ) ) ) ) ) ) . ) )
( Patient ( has ( no malignancy ) ) )
23ec1da4-66c7-11e7-b5f3-f45c89b91419
neutral
She had an MRI as part of her metastatic workup which revealed multiple brain metastases, the largest of which was 1.5cm.
Patient has disease through her body
(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (DT an) (NNP MRI)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (PRP$ her) (JJ metastatic) (NN workup)) (SBAR (WHNP (WDT which)) (S (VP (VBD revealed) (NP (NP (JJ multiple) (NN brain) (NNS metastases)) (, ,) (SBAR (WHNP (NP (DT the) (JJS largest)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBD was) (NP (CD 1.5) (NN cm)))))))))))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN disease)) (PP (IN through) (NP (PRP$ her) (NN body))))))
( She ( ( ( had ( an MRI ) ) ( as ( part ( of ( ( her ( metastatic workup ) ) ( which ( revealed ( ( ( multiple ( brain metastases ) ) , ) ( ( ( the largest ) ( of which ) ) ( was ( 1.5 cm ) ) ) ) ) ) ) ) ) ) ) . ) )
( Patient ( ( has disease ) ( through ( her body ) ) ) )
23ec219c-66c7-11e7-afd2-f45c89b91419
entailment
He was able to keep the milk down and at no time vomited or aspirated.
the patient is an infant
(ROOT (S (NP (PRP He)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VP (VB keep) (NP (DT the) (NN milk)) (PRT (RB down))) (CC and) (S (PP (IN at) (NP (DT no) (NN time))) (VP (VBD vomited) (CC or) (VP (VBD aspirated))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ is) (NP (DT an) (NN infant)))))
( He ( ( was ( able ( to ( ( ( ( keep ( the milk ) ) down ) and ) ( ( at ( no time ) ) ( ( vomited or ) aspirated ) ) ) ) ) ) . ) )
( ( the patient ) ( is ( an infant ) ) )
23ec2380-66c7-11e7-bbab-f45c89b91419
contradiction
He was able to keep the milk down and at no time vomited or aspirated.
the patient is aspirating
(ROOT (S (NP (PRP He)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VP (VB keep) (NP (DT the) (NN milk)) (PRT (RB down))) (CC and) (S (PP (IN at) (NP (DT no) (NN time))) (VP (VBD vomited) (CC or) (VP (VBD aspirated))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ is) (VP (VBG aspirating)))))
( He ( ( was ( able ( to ( ( ( ( keep ( the milk ) ) down ) and ) ( ( at ( no time ) ) ( ( vomited or ) aspirated ) ) ) ) ) ) . ) )
( ( the patient ) ( is aspirating ) )
23ec252c-66c7-11e7-8ba3-f45c89b91419
neutral
He was able to keep the milk down and at no time vomited or aspirated.
the patient is premature
(ROOT (S (NP (PRP He)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VP (VB keep) (NP (DT the) (NN milk)) (PRT (RB down))) (CC and) (S (PP (IN at) (NP (DT no) (NN time))) (VP (VBD vomited) (CC or) (VP (VBD aspirated))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ is) (ADJP (JJ premature)))))
( He ( ( was ( able ( to ( ( ( ( keep ( the milk ) ) down ) and ) ( ( at ( no time ) ) ( ( vomited or ) aspirated ) ) ) ) ) ) . ) )
( ( the patient ) ( is premature ) )
23ec26e4-66c7-11e7-b536-f45c89b91419
entailment
CXR showed low lung volumes, no focal consolidation or pleural effusion, minimal left basilar atelectasis.
Patient has essentially normal chest X-ray
(ROOT (S (NP (NN CXR)) (VP (VBD showed) (SBAR (S (NP (NP (JJ low) (NN lung) (NNS volumes)) (, ,) (NP (NP (DT no) (JJ focal) (NN consolidation)) (CC or) (NP (JJ pleural) (NN effusion))) (, ,) (NP (JJ minimal))) (VP (VBD left) (NP (JJ basilar) (NN atelectasis)))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (ADVP (RB essentially)) (VP (JJ normal) (NP (NN chest) (NN X-ray))))))
( CXR ( ( showed ( ( ( ( ( ( low ( lung volumes ) ) , ) ( ( ( no ( focal consolidation ) ) or ) ( pleural effusion ) ) ) , ) minimal ) ( left ( basilar atelectasis ) ) ) ) . ) )
( Patient ( ( has essentially ) ( normal ( chest X-ray ) ) ) )
23ec289c-66c7-11e7-821e-f45c89b91419
contradiction
CXR showed low lung volumes, no focal consolidation or pleural effusion, minimal left basilar atelectasis.
Patient has well expanded lungs
(ROOT (S (NP (NN CXR)) (VP (VBD showed) (SBAR (S (NP (NP (JJ low) (NN lung) (NNS volumes)) (, ,) (NP (NP (DT no) (JJ focal) (NN consolidation)) (CC or) (NP (JJ pleural) (NN effusion))) (, ,) (NP (JJ minimal))) (VP (VBD left) (NP (JJ basilar) (NN atelectasis)))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (ADVP (RB well)) (VP (VBN expanded) (NP (NNS lungs))))))
( CXR ( ( showed ( ( ( ( ( ( low ( lung volumes ) ) , ) ( ( ( no ( focal consolidation ) ) or ) ( pleural effusion ) ) ) , ) minimal ) ( left ( basilar atelectasis ) ) ) ) . ) )
( Patient ( ( has well ) ( expanded lungs ) ) )
23ec2a40-66c7-11e7-bef3-f45c89b91419
neutral
CXR showed low lung volumes, no focal consolidation or pleural effusion, minimal left basilar atelectasis.
Patient has early aspiration
(ROOT (S (NP (NN CXR)) (VP (VBD showed) (SBAR (S (NP (NP (JJ low) (NN lung) (NNS volumes)) (, ,) (NP (NP (DT no) (JJ focal) (NN consolidation)) (CC or) (NP (JJ pleural) (NN effusion))) (, ,) (NP (JJ minimal))) (VP (VBD left) (NP (JJ basilar) (NN atelectasis)))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ early) (NN aspiration)))))
( CXR ( ( showed ( ( ( ( ( ( low ( lung volumes ) ) , ) ( ( ( no ( focal consolidation ) ) or ) ( pleural effusion ) ) ) , ) minimal ) ( left ( basilar atelectasis ) ) ) ) . ) )
( Patient ( has ( early aspiration ) ) )
23ec2bda-66c7-11e7-a240-f45c89b91419
entailment
The patient denied any cough, dysuria, headache, photophobia, stiff neck, or diarrhea.
The patient does not have pain with urination
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD denied) (NP (NP (DT any) (NN cough)) (, ,) (NP (NN dysuria)) (, ,) (NP (NN headache)) (, ,) (NP (NN photophobia)) (, ,) (NP (JJ stiff) (NN neck)) (, ,) (CC or) (NP (NN diarrhea)))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ does) (RB not) (VP (VB have) (NP (NN pain)) (PP (IN with) (NP (NN urination)))))))
( ( The patient ) ( ( denied ( ( ( ( ( ( ( ( ( ( ( ( any cough ) , ) dysuria ) , ) headache ) , ) photophobia ) , ) ( stiff neck ) ) , ) or ) diarrhea ) ) . ) )
( ( The patient ) ( ( does not ) ( ( have pain ) ( with urination ) ) ) )
23ec2d88-66c7-11e7-84e3-f45c89b91419
contradiction
The patient denied any cough, dysuria, headache, photophobia, stiff neck, or diarrhea.
The patient complains of painful urination
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD denied) (NP (NP (DT any) (NN cough)) (, ,) (NP (NN dysuria)) (, ,) (NP (NN headache)) (, ,) (NP (NN photophobia)) (, ,) (NP (JJ stiff) (NN neck)) (, ,) (CC or) (NP (NN diarrhea)))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ complains) (PP (IN of) (NP (JJ painful) (NN urination))))))
( ( The patient ) ( ( denied ( ( ( ( ( ( ( ( ( ( ( ( any cough ) , ) dysuria ) , ) headache ) , ) photophobia ) , ) ( stiff neck ) ) , ) or ) diarrhea ) ) . ) )
( ( The patient ) ( complains ( of ( painful urination ) ) ) )
23ec3094-66c7-11e7-bd4a-f45c89b91419
neutral
The patient denied any cough, dysuria, headache, photophobia, stiff neck, or diarrhea.
No history of meningitis
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD denied) (NP (NP (DT any) (NN cough)) (, ,) (NP (NN dysuria)) (, ,) (NP (NN headache)) (, ,) (NP (NN photophobia)) (, ,) (NP (JJ stiff) (NN neck)) (, ,) (CC or) (NP (NN diarrhea)))) (. .)))
(ROOT (NP (NP (DT No) (NN history)) (PP (IN of) (NP (NN meningitis)))))
( ( The patient ) ( ( denied ( ( ( ( ( ( ( ( ( ( ( ( any cough ) , ) dysuria ) , ) headache ) , ) photophobia ) , ) ( stiff neck ) ) , ) or ) diarrhea ) ) . ) )
( ( No history ) ( of meningitis ) )
23ec3b0c-66c7-11e7-9a5b-f45c89b91419
entailment
She is currently in stable condition and off of pressors and IABP.
She was treated for a cardiac condition
(ROOT (S (NP (PRP She)) (VP (VBZ is) (ADVP (RB currently)) (PP (PP (IN in) (NP (JJ stable) (NN condition))) (CC and) (PP (IN off) (PP (IN of) (NP (NP (NNS pressors)) (CC and) (NP (NN IABP))))))) (. .)))
(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN treated) (PP (IN for) (NP (DT a) (JJ cardiac) (NN condition)))))))
( She ( ( ( is currently ) ( ( ( in ( stable condition ) ) and ) ( off ( of ( ( pressors and ) IABP ) ) ) ) ) . ) )
( She ( was ( treated ( for ( a ( cardiac condition ) ) ) ) ) )
23ec3d6e-66c7-11e7-9a7a-f45c89b91419
contradiction
She is currently in stable condition and off of pressors and IABP.
She has no history of cardiac disease
(ROOT (S (NP (PRP She)) (VP (VBZ is) (ADVP (RB currently)) (PP (PP (IN in) (NP (JJ stable) (NN condition))) (CC and) (PP (IN off) (PP (IN of) (NP (NP (NNS pressors)) (CC and) (NP (NN IABP))))))) (. .)))
(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (JJ cardiac) (NN disease)))))))
( She ( ( ( is currently ) ( ( ( in ( stable condition ) ) and ) ( off ( of ( ( pressors and ) IABP ) ) ) ) ) . ) )
( She ( has ( ( no history ) ( of ( cardiac disease ) ) ) ) )
23ec3f3a-66c7-11e7-88e5-f45c89b91419
neutral
She is currently in stable condition and off of pressors and IABP.
She has a history of myocardial infarction
(ROOT (S (NP (PRP She)) (VP (VBZ is) (ADVP (RB currently)) (PP (PP (IN in) (NP (JJ stable) (NN condition))) (CC and) (PP (IN off) (PP (IN of) (NP (NP (NNS pressors)) (CC and) (NP (NN IABP))))))) (. .)))
(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ myocardial) (NN infarction)))))))
( She ( ( ( is currently ) ( ( ( in ( stable condition ) ) and ) ( off ( of ( ( pressors and ) IABP ) ) ) ) ) . ) )
( She ( has ( ( a history ) ( of ( myocardial infarction ) ) ) ) )
23ec40e8-66c7-11e7-a2e2-f45c89b91419
entailment
He was given depakote for seizure prevention as well as ativan.
the patient has a history of seizures
(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN given) (NP (NP (NN depakote)) (PP (IN for) (NP (NN seizure) (NN prevention)))) (FRAG (CONJP (RB as) (RB well) (IN as)) (NP (NN ativan))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS seizures)))))))
( He ( ( was ( ( given ( depakote ( for ( seizure prevention ) ) ) ) ( ( as ( well as ) ) ativan ) ) ) . ) )
( ( the patient ) ( has ( ( a history ) ( of seizures ) ) ) )
23ec428c-66c7-11e7-8b43-f45c89b91419
contradiction
He was given depakote for seizure prevention as well as ativan.
the patient has no history of seizures
(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN given) (NP (NP (NN depakote)) (PP (IN for) (NP (NN seizure) (NN prevention)))) (FRAG (CONJP (RB as) (RB well) (IN as)) (NP (NN ativan))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (NNS seizures)))))))
( He ( ( was ( ( given ( depakote ( for ( seizure prevention ) ) ) ) ( ( as ( well as ) ) ativan ) ) ) . ) )
( ( the patient ) ( has ( ( no history ) ( of seizures ) ) ) )
23ec4426-66c7-11e7-98a2-f45c89b91419
neutral
He was given depakote for seizure prevention as well as ativan.
the patient has a brain tumor
(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN given) (NP (NP (NN depakote)) (PP (IN for) (NP (NN seizure) (NN prevention)))) (FRAG (CONJP (RB as) (RB well) (IN as)) (NP (NN ativan))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (DT a) (NN brain) (NN tumor)))))
( He ( ( was ( ( given ( depakote ( for ( seizure prevention ) ) ) ) ( ( as ( well as ) ) ativan ) ) ) . ) )
( ( the patient ) ( has ( a ( brain tumor ) ) ) )
23ec4612-66c7-11e7-b055-f45c89b91419
entailment
75 y/o M w/ atrial fibrillation, HTN, dyslipidemia, and DVT (while on coumadin so now on lovenox) who persented with a 1 day history of worsening SOB and cough productive of clear sputum.
the patient has shortness of breath
(ROOT (FRAG (NP (CD 75) (NN y/o) (NN M) (NN w)) (: /) (NP (NP (JJ atrial) (NN fibrillation) (, ,) (NN HTN) (, ,) (NN dyslipidemia) (, ,) (CC and) (NX (NNP DVT) (PRN (-LRB- -LRB-) (IN while) (PP (IN on) (NP (NN coumadin))) (LST (PP (ADVP (RB so) (RB now)) (IN on) (NP (NN lovenox))) (-RRB- -RRB-))))) (SBAR (WHNP (WP who)) (S (VP (VBD persented) (PP (IN with) (NP (NP (DT a) (ADJP (CD 1) (NN day)) (NN history)) (PP (IN of) (S (VP (VBG worsening) (NP (NP (NP (NN SOB)) (CC and) (NP (NN cough))) (ADJP (JJ productive) (PP (IN of) (NP (JJ clear) (NN sputum)))))))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NP (NN shortness)) (PP (IN of) (NP (NN breath)))))))
( ( 75 ( y/o ( M w ) ) ) ( / ( ( ( atrial ( fibrillation ( , ( HTN ( , ( dyslipidemia ( , ( and ( DVT ( -LRB- ( while ( ( on coumadin ) ( ( ( so now ) ( on lovenox ) ) -RRB- ) ) ) ) ) ) ) ) ) ) ) ) ) ( who ( persented ( with ( ( a ( ( 1 day ) history ) ) ( of ( worsening ( ( ( SOB and ) cough ) ( productive ( of ( clear sputum ) ) ) ) ) ) ) ) ) ) ) . ) ) )
( ( the patient ) ( has ( shortness ( of breath ) ) ) )
23ec4822-66c7-11e7-9b02-f45c89b91419
contradiction
75 y/o M w/ atrial fibrillation, HTN, dyslipidemia, and DVT (while on coumadin so now on lovenox) who persented with a 1 day history of worsening SOB and cough productive of clear sputum.
the patient denies difficulty breathing
(ROOT (FRAG (NP (CD 75) (NN y/o) (NN M) (NN w)) (: /) (NP (NP (JJ atrial) (NN fibrillation) (, ,) (NN HTN) (, ,) (NN dyslipidemia) (, ,) (CC and) (NX (NNP DVT) (PRN (-LRB- -LRB-) (IN while) (PP (IN on) (NP (NN coumadin))) (LST (PP (ADVP (RB so) (RB now)) (IN on) (NP (NN lovenox))) (-RRB- -RRB-))))) (SBAR (WHNP (WP who)) (S (VP (VBD persented) (PP (IN with) (NP (NP (DT a) (ADJP (CD 1) (NN day)) (NN history)) (PP (IN of) (S (VP (VBG worsening) (NP (NP (NP (NN SOB)) (CC and) (NP (NN cough))) (ADJP (JJ productive) (PP (IN of) (NP (JJ clear) (NN sputum)))))))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ denies) (NP (NN difficulty) (NN breathing)))))
( ( 75 ( y/o ( M w ) ) ) ( / ( ( ( atrial ( fibrillation ( , ( HTN ( , ( dyslipidemia ( , ( and ( DVT ( -LRB- ( while ( ( on coumadin ) ( ( ( so now ) ( on lovenox ) ) -RRB- ) ) ) ) ) ) ) ) ) ) ) ) ) ( who ( persented ( with ( ( a ( ( 1 day ) history ) ) ( of ( worsening ( ( ( SOB and ) cough ) ( productive ( of ( clear sputum ) ) ) ) ) ) ) ) ) ) ) . ) ) )
( ( the patient ) ( denies ( difficulty breathing ) ) )
23ec4a28-66c7-11e7-8032-f45c89b91419
neutral
75 y/o M w/ atrial fibrillation, HTN, dyslipidemia, and DVT (while on coumadin so now on lovenox) who persented with a 1 day history of worsening SOB and cough productive of clear sputum.
the patient has pneumonia
(ROOT (FRAG (NP (CD 75) (NN y/o) (NN M) (NN w)) (: /) (NP (NP (JJ atrial) (NN fibrillation) (, ,) (NN HTN) (, ,) (NN dyslipidemia) (, ,) (CC and) (NX (NNP DVT) (PRN (-LRB- -LRB-) (IN while) (PP (IN on) (NP (NN coumadin))) (LST (PP (ADVP (RB so) (RB now)) (IN on) (NP (NN lovenox))) (-RRB- -RRB-))))) (SBAR (WHNP (WP who)) (S (VP (VBD persented) (PP (IN with) (NP (NP (DT a) (ADJP (CD 1) (NN day)) (NN history)) (PP (IN of) (S (VP (VBG worsening) (NP (NP (NP (NN SOB)) (CC and) (NP (NN cough))) (ADJP (JJ productive) (PP (IN of) (NP (JJ clear) (NN sputum)))))))))))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NN pneumonia)))))
( ( 75 ( y/o ( M w ) ) ) ( / ( ( ( atrial ( fibrillation ( , ( HTN ( , ( dyslipidemia ( , ( and ( DVT ( -LRB- ( while ( ( on coumadin ) ( ( ( so now ) ( on lovenox ) ) -RRB- ) ) ) ) ) ) ) ) ) ) ) ) ) ( who ( persented ( with ( ( a ( ( 1 day ) history ) ) ( of ( worsening ( ( ( SOB and ) cough ) ( productive ( of ( clear sputum ) ) ) ) ) ) ) ) ) ) ) . ) ) )
( ( the patient ) ( has pneumonia ) )
23ec4dec-66c7-11e7-807b-f45c89b91419
entailment
History of TIA [**5-/3025**] with left hemi[** Location **] that resolved.
Patient has a focal neurological deficit
(ROOT (NP (NP (NP (NP (NN History)) (PP (IN of) (NP (NN TIA)))) (PRN (-LRB- -LSB-) (NP (SYM **) (LS 5) (: -) (: /) (CD 3025) (X (SYM **)) (ADVP (-RRB- -RSB-) (NP (VP (PP (IN with) (NP (NP (JJ left) (NN hemi)) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-)) (SBAR (WHNP (WDT that)) (S (VP (VBD resolved)))))))))))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT a) (JJ focal) (JJ neurological) (NN deficit)))))
( ( ( History ( of TIA ) ) ( -LSB- ( ** ( 5 ( - ( / ( ( 3025 ** ) ( -RSB- ( with ( ( left hemi ) ( -LSB- ( ( ** ( ( Location ** ) -RSB- ) ) ( that resolved ) ) ) ) ) ) ) ) ) ) ) ) ) . )
( Patient ( has ( a ( focal ( neurological deficit ) ) ) ) )
23ec4fd4-66c7-11e7-acb3-f45c89b91419
contradiction
History of TIA [**5-/3025**] with left hemi[** Location **] that resolved.
Patient has no symptoms
(ROOT (NP (NP (NP (NP (NN History)) (PP (IN of) (NP (NN TIA)))) (PRN (-LRB- -LSB-) (NP (SYM **) (LS 5) (: -) (: /) (CD 3025) (X (SYM **)) (ADVP (-RRB- -RSB-) (NP (VP (PP (IN with) (NP (NP (JJ left) (NN hemi)) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-)) (SBAR (WHNP (WDT that)) (S (VP (VBD resolved)))))))))))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (NNS symptoms)))))
( ( ( History ( of TIA ) ) ( -LSB- ( ** ( 5 ( - ( / ( ( 3025 ** ) ( -RSB- ( with ( ( left hemi ) ( -LSB- ( ( ** ( ( Location ** ) -RSB- ) ) ( that resolved ) ) ) ) ) ) ) ) ) ) ) ) ) . )
( Patient ( has ( no symptoms ) ) )
23ec5240-66c7-11e7-91f6-f45c89b91419
neutral
History of TIA [**5-/3025**] with left hemi[** Location **] that resolved.
Patient has abnormal brain MRI
(ROOT (NP (NP (NP (NP (NN History)) (PP (IN of) (NP (NN TIA)))) (PRN (-LRB- -LSB-) (NP (SYM **) (LS 5) (: -) (: /) (CD 3025) (X (SYM **)) (ADVP (-RRB- -RSB-) (NP (VP (PP (IN with) (NP (NP (JJ left) (NN hemi)) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-)) (SBAR (WHNP (WDT that)) (S (VP (VBD resolved)))))))))))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ abnormal) (NN brain) (NNP MRI)))))
( ( ( History ( of TIA ) ) ( -LSB- ( ** ( 5 ( - ( / ( ( 3025 ** ) ( -RSB- ( with ( ( left hemi ) ( -LSB- ( ( ** ( ( Location ** ) -RSB- ) ) ( that resolved ) ) ) ) ) ) ) ) ) ) ) ) ) . )
( Patient ( has ( abnormal ( brain MRI ) ) ) )
23ec5592-66c7-11e7-b590-f45c89b91419
entailment
Her abdominal exam was benign.
The patient does not have an abdominal exam concerning for an infection.
(ROOT (S (NP (PRP$ Her) (JJ abdominal) (NN exam)) (VP (VBD was) (ADJP (JJ benign))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ does) (RB not) (VP (VB have) (NP (NP (DT an) (JJ abdominal) (NN exam)) (VP (VBG concerning) (PP (IN for) (NP (DT an) (NN infection))))))) (. .)))
( ( Her ( abdominal exam ) ) ( ( was benign ) . ) )
( ( The patient ) ( ( ( does not ) ( have ( ( an ( abdominal exam ) ) ( concerning ( for ( an infection ) ) ) ) ) ) . ) )
23ec5770-66c7-11e7-9c6d-f45c89b91419
contradiction
Her abdominal exam was benign.
The patient has peritoneal signs.
(ROOT (S (NP (PRP$ Her) (JJ abdominal) (NN exam)) (VP (VBD was) (ADJP (JJ benign))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ peritoneal) (NNS signs))) (. .)))
( ( Her ( abdominal exam ) ) ( ( was benign ) . ) )
( ( The patient ) ( ( has ( peritoneal signs ) ) . ) )
23ec5982-66c7-11e7-8e62-f45c89b91419
neutral
Her abdominal exam was benign.
The patient does not have an acute intraabdominal process.
(ROOT (S (NP (PRP$ Her) (JJ abdominal) (NN exam)) (VP (VBD was) (ADJP (JJ benign))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ does) (RB not) (VP (VB have) (NP (DT an) (JJ acute) (JJ intraabdominal) (NN process)))) (. .)))
( ( Her ( abdominal exam ) ) ( ( was benign ) . ) )
( ( The patient ) ( ( ( does not ) ( have ( an ( acute ( intraabdominal process ) ) ) ) ) . ) )
23ec5bb4-66c7-11e7-bf8b-f45c89b91419
entailment
GASTROINTESTINAL: [**Known patient lastname 635**] was started on Reglan and Zantac on [**10-16**] to maximize medical therapy that may be contributing to his apneic and bradycardic episodes.
He has had slow heart rate and suspension of breathing
(ROOT (S (NP (NP (NN GASTROINTESTINAL)) (: :) (PRN (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (NN lastname) (CD 635) (X (SYM **))) (-RRB- -RSB-))) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NNP Reglan) (CC and) (NNP Zantac))) (SBAR (IN on) (SINV (-LRB- -LSB-) (NP (SYM **) (CD 10-16) (X (SYM **)) (VP (-RRB- -RSB-) (S (VP (TO to) (VP (VB maximize) (NP (NP (JJ medical) (NN therapy)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (VP (VBG contributing) (PP (TO to) (NP (PRP$ his) (ADJP (JJ apneic) (CC and) (JJ bradycardic)) (NNS episodes)))))))))))))))))) (. .)))
(ROOT (S (NP (PRP He)) (VP (VBZ has) (VP (VBN had) (NP (NP (JJ slow) (NN heart) (NN rate)) (CC and) (NP (NP (NN suspension)) (PP (IN of) (NP (NN breathing)))))))))
( ( ( GASTROINTESTINAL : ) ( -LSB- ( ( ** ( Known ( patient ( ( lastname 635 ) ** ) ) ) ) -RSB- ) ) ) ( ( was ( ( started ( on ( ( Reglan and ) Zantac ) ) ) ( on ( -LSB- ( ** ( ( 10-16 ** ) ( -RSB- ( to ( maximize ( ( medical therapy ) ( that ( may ( be ( contributing ( to ( his ( ( ( apneic and ) bradycardic ) episodes ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( He ( has ( had ( ( ( slow ( heart rate ) ) and ) ( suspension ( of breathing ) ) ) ) ) )
23ec5e02-66c7-11e7-97bf-f45c89b91419
contradiction
GASTROINTESTINAL: [**Known patient lastname 635**] was started on Reglan and Zantac on [**10-16**] to maximize medical therapy that may be contributing to his apneic and bradycardic episodes.
His breathing and heart rate have been normal
(ROOT (S (NP (NP (NN GASTROINTESTINAL)) (: :) (PRN (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (NN lastname) (CD 635) (X (SYM **))) (-RRB- -RSB-))) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NNP Reglan) (CC and) (NNP Zantac))) (SBAR (IN on) (SINV (-LRB- -LSB-) (NP (SYM **) (CD 10-16) (X (SYM **)) (VP (-RRB- -RSB-) (S (VP (TO to) (VP (VB maximize) (NP (NP (JJ medical) (NN therapy)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (VP (VBG contributing) (PP (TO to) (NP (PRP$ his) (ADJP (JJ apneic) (CC and) (JJ bradycardic)) (NNS episodes)))))))))))))))))) (. .)))
(ROOT (S (NP (NP (PRP$ His) (NN breathing)) (CC and) (NP (NN heart) (NN rate))) (VP (VBP have) (VP (VBN been) (ADJP (JJ normal))))))
( ( ( GASTROINTESTINAL : ) ( -LSB- ( ( ** ( Known ( patient ( ( lastname 635 ) ** ) ) ) ) -RSB- ) ) ) ( ( was ( ( started ( on ( ( Reglan and ) Zantac ) ) ) ( on ( -LSB- ( ** ( ( 10-16 ** ) ( -RSB- ( to ( maximize ( ( medical therapy ) ( that ( may ( be ( contributing ( to ( his ( ( ( apneic and ) bradycardic ) episodes ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( ( ( His breathing ) and ) ( heart rate ) ) ( have ( been normal ) ) )
23ec61ae-66c7-11e7-be8c-f45c89b91419
neutral
GASTROINTESTINAL: [**Known patient lastname 635**] was started on Reglan and Zantac on [**10-16**] to maximize medical therapy that may be contributing to his apneic and bradycardic episodes.
He has a history of obesity
(ROOT (S (NP (NP (NN GASTROINTESTINAL)) (: :) (PRN (-LRB- -LSB-) (NP (SYM **) (VBN Known) (NN patient) (NN lastname) (CD 635) (X (SYM **))) (-RRB- -RSB-))) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NNP Reglan) (CC and) (NNP Zantac))) (SBAR (IN on) (SINV (-LRB- -LSB-) (NP (SYM **) (CD 10-16) (X (SYM **)) (VP (-RRB- -RSB-) (S (VP (TO to) (VP (VB maximize) (NP (NP (JJ medical) (NN therapy)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (VP (VBG contributing) (PP (TO to) (NP (PRP$ his) (ADJP (JJ apneic) (CC and) (JJ bradycardic)) (NNS episodes)))))))))))))))))) (. .)))
(ROOT (S (NP (PRP He)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN obesity)))))))
( ( ( GASTROINTESTINAL : ) ( -LSB- ( ( ** ( Known ( patient ( ( lastname 635 ) ** ) ) ) ) -RSB- ) ) ) ( ( was ( ( started ( on ( ( Reglan and ) Zantac ) ) ) ( on ( -LSB- ( ** ( ( 10-16 ** ) ( -RSB- ( to ( maximize ( ( medical therapy ) ( that ( may ( be ( contributing ( to ( his ( ( ( apneic and ) bradycardic ) episodes ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( He ( has ( ( a history ) ( of obesity ) ) ) )
23ec650a-66c7-11e7-943f-f45c89b91419
entailment
He took some oxycodone without relief.
He had pain
(ROOT (S (NP (PRP He)) (VP (VBD took) (NP (DT some) (NN oxycodone)) (PP (IN without) (NP (NN relief)))) (. .)))
(ROOT (S (NP (PRP He)) (VP (VBD had) (NP (NN pain)))))
( He ( ( ( took ( some oxycodone ) ) ( without relief ) ) . ) )
( He ( had pain ) )
23ec6708-66c7-11e7-98e9-f45c89b91419
contradiction
He took some oxycodone without relief.
He has no pain
(ROOT (S (NP (PRP He)) (VP (VBD took) (NP (DT some) (NN oxycodone)) (PP (IN without) (NP (NN relief)))) (. .)))
(ROOT (S (NP (PRP He)) (VP (VBZ has) (NP (DT no) (NN pain)))))
( He ( ( ( took ( some oxycodone ) ) ( without relief ) ) . ) )
( He ( has ( no pain ) ) )
23ec68ac-66c7-11e7-bc27-f45c89b91419
neutral
He took some oxycodone without relief.
He has abdominal pain
(ROOT (S (NP (PRP He)) (VP (VBD took) (NP (DT some) (NN oxycodone)) (PP (IN without) (NP (NN relief)))) (. .)))
(ROOT (S (NP (PRP He)) (VP (VBZ has) (NP (JJ abdominal) (NN pain)))))
( He ( ( ( took ( some oxycodone ) ) ( without relief ) ) . ) )
( He ( has ( abdominal pain ) ) )
23ec6a64-66c7-11e7-8eae-f45c89b91419
entailment
VRE septic thrombophlebitis in IJ ([**1-19**]) s/p linezolid) 6.
the patient had an infection in the ij
(ROOT (FRAG (NP (NP (NN VRE) (JJ septic) (NN thrombophlebitis)) (PP (IN in) (NP (NN IJ))) (PRN (-LRB- -LRB-) (PRN (PRN (-LRB- -LSB-) (NP (SYM **) (CD 1-19) (X (SYM **)) (-RRB- -RSB-) (-RRB- -RRB-) (NN s/p) (NN linezolid)) (-RRB- -RRB-)) (QP (CD 6))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBD had) (NP (DT an) (NN infection)) (PP (IN in) (NP (DT the) (NN ij))))))
( ( ( ( VRE ( septic thrombophlebitis ) ) ( in IJ ) ) ( -LRB- ( ( -LSB- ( ( ** ( 1-19 ( ** ( -RSB- ( -RRB- ( s/p linezolid ) ) ) ) ) ) -RRB- ) ) 6 ) ) ) . )
( ( the patient ) ( ( had ( an infection ) ) ( in ( the ij ) ) ) )
23ec6c38-66c7-11e7-95e8-f45c89b91419
contradiction
VRE septic thrombophlebitis in IJ ([**1-19**]) s/p linezolid) 6.
the patient has no history of infection
(ROOT (FRAG (NP (NP (NN VRE) (JJ septic) (NN thrombophlebitis)) (PP (IN in) (NP (NN IJ))) (PRN (-LRB- -LRB-) (PRN (PRN (-LRB- -LSB-) (NP (SYM **) (CD 1-19) (X (SYM **)) (-RRB- -RSB-) (-RRB- -RRB-) (NN s/p) (NN linezolid)) (-RRB- -RRB-)) (QP (CD 6))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (NN infection)))))))
( ( ( ( VRE ( septic thrombophlebitis ) ) ( in IJ ) ) ( -LRB- ( ( -LSB- ( ( ** ( 1-19 ( ** ( -RSB- ( -RRB- ( s/p linezolid ) ) ) ) ) ) -RRB- ) ) 6 ) ) ) . )
( ( the patient ) ( has ( ( no history ) ( of infection ) ) ) )
23ec6dfa-66c7-11e7-a85e-f45c89b91419
neutral
VRE septic thrombophlebitis in IJ ([**1-19**]) s/p linezolid) 6.
the patient had a central line
(ROOT (FRAG (NP (NP (NN VRE) (JJ septic) (NN thrombophlebitis)) (PP (IN in) (NP (NN IJ))) (PRN (-LRB- -LRB-) (PRN (PRN (-LRB- -LSB-) (NP (SYM **) (CD 1-19) (X (SYM **)) (-RRB- -RSB-) (-RRB- -RRB-) (NN s/p) (NN linezolid)) (-RRB- -RRB-)) (QP (CD 6))))) (. .)))
(ROOT (S (NP (DT the) (NN patient)) (VP (VBD had) (NP (DT a) (JJ central) (NN line)))))
( ( ( ( VRE ( septic thrombophlebitis ) ) ( in IJ ) ) ( -LRB- ( ( -LSB- ( ( ** ( 1-19 ( ** ( -RSB- ( -RRB- ( s/p linezolid ) ) ) ) ) ) -RRB- ) ) 6 ) ) ) . )
( ( the patient ) ( had ( a ( central line ) ) ) )
23ec6ff0-66c7-11e7-b597-f45c89b91419
entailment
She was seen by ID at [**Hospital1 294**] on [**6-17**] who felt this was less likely an infectious process.
The patient was evaluated by infectious disease specialists
(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN seen) (PP (IN by) (NP (NP (NN ID)) (PP (IN at) (S (-LRB- -LSB-) (VP (SYM **) (SBAR (S (NP (NN Hospital1) (CD 294)) (VP (X (SYM **)) (S (VP (-RRB- -RSB-) (PP (IN on) (NP (NP (-LRB- -LSB-) (SYM **) (CD 6-17) (X (SYM **)) (-RRB- -RSB-)) (SBAR (WHNP (WP who)) (S (VP (VBD felt) (SBAR (S (NP (DT this)) (VP (VBD was) (NP (ADJP (RBR less) (JJ likely)) (DT an) (JJ infectious) (NN process)))))))))))))))))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN evaluated) (PP (IN by) (NP (JJ infectious) (NN disease) (NNS specialists)))))))
( She ( ( was ( seen ( by ( ID ( at ( -LSB- ( ** ( ( Hospital1 294 ) ( ** ( -RSB- ( on ( ( -LSB- ( ** ( ( 6-17 ** ) -RSB- ) ) ) ( who ( felt ( this ( was ( ( less likely ) ( an ( infectious process ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( was ( evaluated ( by ( infectious ( disease specialists ) ) ) ) ) )
23ec7778-66c7-11e7-a618-f45c89b91419
contradiction
She was seen by ID at [**Hospital1 294**] on [**6-17**] who felt this was less likely an infectious process.
The patient was suspected to have tuberculosis
(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN seen) (PP (IN by) (NP (NP (NN ID)) (PP (IN at) (S (-LRB- -LSB-) (VP (SYM **) (SBAR (S (NP (NN Hospital1) (CD 294)) (VP (X (SYM **)) (S (VP (-RRB- -RSB-) (PP (IN on) (NP (NP (-LRB- -LSB-) (SYM **) (CD 6-17) (X (SYM **)) (-RRB- -RSB-)) (SBAR (WHNP (WP who)) (S (VP (VBD felt) (SBAR (S (NP (DT this)) (VP (VBD was) (NP (ADJP (RBR less) (JJ likely)) (DT an) (JJ infectious) (NN process)))))))))))))))))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN suspected) (S (VP (TO to) (VP (VB have) (NP (NN tuberculosis)))))))))
( She ( ( was ( seen ( by ( ID ( at ( -LSB- ( ** ( ( Hospital1 294 ) ( ** ( -RSB- ( on ( ( -LSB- ( ** ( ( 6-17 ** ) -RSB- ) ) ) ( who ( felt ( this ( was ( ( less likely ) ( an ( infectious process ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( was ( suspected ( to ( have tuberculosis ) ) ) ) )
23ec7b42-66c7-11e7-9dc6-f45c89b91419
neutral
She was seen by ID at [**Hospital1 294**] on [**6-17**] who felt this was less likely an infectious process.
The patient has a fever and elevated white count
(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN seen) (PP (IN by) (NP (NP (NN ID)) (PP (IN at) (S (-LRB- -LSB-) (VP (SYM **) (SBAR (S (NP (NN Hospital1) (CD 294)) (VP (X (SYM **)) (S (VP (-RRB- -RSB-) (PP (IN on) (NP (NP (-LRB- -LSB-) (SYM **) (CD 6-17) (X (SYM **)) (-RRB- -RSB-)) (SBAR (WHNP (WP who)) (S (VP (VBD felt) (SBAR (S (NP (DT this)) (VP (VBD was) (NP (ADJP (RBR less) (JJ likely)) (DT an) (JJ infectious) (NN process)))))))))))))))))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (NX (NX (NN fever)) (CC and) (NX (JJ elevated) (JJ white) (NN count)))))))
( She ( ( was ( seen ( by ( ID ( at ( -LSB- ( ** ( ( Hospital1 294 ) ( ** ( -RSB- ( on ( ( -LSB- ( ** ( ( 6-17 ** ) -RSB- ) ) ) ( who ( felt ( this ( was ( ( less likely ) ( an ( infectious process ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( ( The patient ) ( has ( a ( ( fever and ) ( elevated ( white count ) ) ) ) ) )
23ec7d8a-66c7-11e7-8550-f45c89b91419
entailment
Pacemaker for sick sinus syndrome.
Pacemakers are used for symptomatic arrhythmias.
(ROOT (NP (NP (NN Pacemaker)) (PP (IN for) (NP (JJ sick) (NN sinus) (NN syndrome))) (. .)))
(ROOT (S (NP (NNS Pacemakers)) (VP (VBP are) (VP (VBN used) (PP (IN for) (NP (JJ symptomatic) (NNS arrhythmias))))) (. .)))
( ( Pacemaker ( for ( sick ( sinus syndrome ) ) ) ) . )
( Pacemakers ( ( are ( used ( for ( symptomatic arrhythmias ) ) ) ) . ) )
23ec7f54-66c7-11e7-b39c-f45c89b91419
contradiction
Pacemaker for sick sinus syndrome.
Pacemakers are used for pulmonary edema.
(ROOT (NP (NP (NN Pacemaker)) (PP (IN for) (NP (JJ sick) (NN sinus) (NN syndrome))) (. .)))
(ROOT (S (NP (NNS Pacemakers)) (VP (VBP are) (VP (VBN used) (PP (IN for) (NP (JJ pulmonary) (NN edema))))) (. .)))
( ( Pacemaker ( for ( sick ( sinus syndrome ) ) ) ) . )
( Pacemakers ( ( are ( used ( for ( pulmonary edema ) ) ) ) . ) )
23ec80f8-66c7-11e7-9771-f45c89b91419
neutral
Pacemaker for sick sinus syndrome.
Patients with a pacemakers have atrial fibrillation.
(ROOT (NP (NP (NN Pacemaker)) (PP (IN for) (NP (JJ sick) (NN sinus) (NN syndrome))) (. .)))
(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (DT a) (NNS pacemakers)))) (VP (VBP have) (NP (JJ atrial) (NN fibrillation))) (. .)))
( ( Pacemaker ( for ( sick ( sinus syndrome ) ) ) ) . )
( ( Patients ( with ( a pacemakers ) ) ) ( ( have ( atrial fibrillation ) ) . ) )
23ec83be-66c7-11e7-b294-f45c89b91419
entailment
EMS found her at home where she admitted to ingesting 60mg Cymbalta, 12mg Cyproheptadine, and 22mg Klonopin with an entire bottle of wine (750cc).
She intentionally overdosed on prescription medication
(ROOT (S (NP (NNP EMS)) (VP (VBD found) (NP (PRP$ her)) (PP (IN at) (NP (NN home))) (SBAR (WHADVP (WRB where)) (S (NP (PRP she)) (VP (VBD admitted) (PP (TO to) (S (VP (VBG ingesting) (NP (NP (JJ 60mg) (NNP Cymbalta)) (, ,) (NP (CD 12mg) (NN Cyproheptadine)) (, ,) (CC and) (NP (NP (JJ 22mg) (NN Klonopin)) (PP (IN with) (NP (NP (DT an) (JJ entire) (NN bottle)) (PP (IN of) (NP (NP (NN wine)) (PRN (-LRB- -LRB-) (NP (NN 750cc)) (-RRB- -RRB-))))))))))))))) (. .)))
(ROOT (S (NP (PRP She)) (ADVP (RB intentionally)) (VP (VBD overdosed) (PP (IN on) (NP (NN prescription) (NN medication))))))
( EMS ( ( ( ( found her ) ( at home ) ) ( where ( she ( admitted ( to ( ingesting ( ( ( ( ( ( 60mg Cymbalta ) , ) ( 12mg Cyproheptadine ) ) , ) and ) ( ( 22mg Klonopin ) ( with ( ( an ( entire bottle ) ) ( of ( wine ( -LRB- ( 750cc -RRB- ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( She ( intentionally ( overdosed ( on ( prescription medication ) ) ) ) )
23ec8666-66c7-11e7-aea1-f45c89b91419
contradiction
EMS found her at home where she admitted to ingesting 60mg Cymbalta, 12mg Cyproheptadine, and 22mg Klonopin with an entire bottle of wine (750cc).
She ingested no medication
(ROOT (S (NP (NNP EMS)) (VP (VBD found) (NP (PRP$ her)) (PP (IN at) (NP (NN home))) (SBAR (WHADVP (WRB where)) (S (NP (PRP she)) (VP (VBD admitted) (PP (TO to) (S (VP (VBG ingesting) (NP (NP (JJ 60mg) (NNP Cymbalta)) (, ,) (NP (CD 12mg) (NN Cyproheptadine)) (, ,) (CC and) (NP (NP (JJ 22mg) (NN Klonopin)) (PP (IN with) (NP (NP (DT an) (JJ entire) (NN bottle)) (PP (IN of) (NP (NP (NN wine)) (PRN (-LRB- -LRB-) (NP (NN 750cc)) (-RRB- -RRB-))))))))))))))) (. .)))
(ROOT (S (NP (PRP She)) (VP (VBD ingested) (NP (DT no) (NN medication)))))
( EMS ( ( ( ( found her ) ( at home ) ) ( where ( she ( admitted ( to ( ingesting ( ( ( ( ( ( 60mg Cymbalta ) , ) ( 12mg Cyproheptadine ) ) , ) and ) ( ( 22mg Klonopin ) ( with ( ( an ( entire bottle ) ) ( of ( wine ( -LRB- ( 750cc -RRB- ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( She ( ingested ( no medication ) ) )
23ec899c-66c7-11e7-bc06-f45c89b91419
neutral
EMS found her at home where she admitted to ingesting 60mg Cymbalta, 12mg Cyproheptadine, and 22mg Klonopin with an entire bottle of wine (750cc).
She has a history of depression
(ROOT (S (NP (NNP EMS)) (VP (VBD found) (NP (PRP$ her)) (PP (IN at) (NP (NN home))) (SBAR (WHADVP (WRB where)) (S (NP (PRP she)) (VP (VBD admitted) (PP (TO to) (S (VP (VBG ingesting) (NP (NP (JJ 60mg) (NNP Cymbalta)) (, ,) (NP (CD 12mg) (NN Cyproheptadine)) (, ,) (CC and) (NP (NP (JJ 22mg) (NN Klonopin)) (PP (IN with) (NP (NP (DT an) (JJ entire) (NN bottle)) (PP (IN of) (NP (NP (NN wine)) (PRN (-LRB- -LRB-) (NP (NN 750cc)) (-RRB- -RRB-))))))))))))))) (. .)))
(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN depression)))))))
( EMS ( ( ( ( found her ) ( at home ) ) ( where ( she ( admitted ( to ( ingesting ( ( ( ( ( ( 60mg Cymbalta ) , ) ( 12mg Cyproheptadine ) ) , ) and ) ( ( 22mg Klonopin ) ( with ( ( an ( entire bottle ) ) ( of ( wine ( -LRB- ( 750cc -RRB- ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )
( She ( has ( ( a history ) ( of depression ) ) ) )
23ec8d82-66c7-11e7-b3b2-f45c89b91419
entailment
He underwent partial vertebrectomy, fusion, debridement, and vertebral spacer placement at L3-L4 on [**3313-12-1**]. .
Patient has had spinal intervention
(ROOT (S (NP (PRP He)) (VP (VBD underwent) (NP (NP (JJ partial) (NN vertebrectomy)) (, ,) (NP (NN fusion)) (, ,) (NP (NN debridement)) (, ,) (CC and) (NP (NP (JJ vertebral) (NN spacer) (NN placement)) (PP (IN at) (NP (NN L3-L4))))) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 3313-12-1) (FRAG (X (SYM **)) (-RRB- -RSB-) (. .))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN had) (NP (JJ spinal) (NN intervention))))))
( He ( ( ( underwent ( ( ( ( ( ( ( ( partial vertebrectomy ) , ) fusion ) , ) debridement ) , ) and ) ( ( vertebral ( spacer placement ) ) ( at L3-L4 ) ) ) ) ( on ( -LSB- ( ** ( 3313-12-1 ( ( ** -RSB- ) . ) ) ) ) ) ) . ) )
( Patient ( has ( had ( spinal intervention ) ) ) )
23ec8fc6-66c7-11e7-8bdc-f45c89b91419
contradiction
He underwent partial vertebrectomy, fusion, debridement, and vertebral spacer placement at L3-L4 on [**3313-12-1**]. .
Patient has no PSH
(ROOT (S (NP (PRP He)) (VP (VBD underwent) (NP (NP (JJ partial) (NN vertebrectomy)) (, ,) (NP (NN fusion)) (, ,) (NP (NN debridement)) (, ,) (CC and) (NP (NP (JJ vertebral) (NN spacer) (NN placement)) (PP (IN at) (NP (NN L3-L4))))) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 3313-12-1) (FRAG (X (SYM **)) (-RRB- -RSB-) (. .))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (NN PSH)))))
( He ( ( ( underwent ( ( ( ( ( ( ( ( partial vertebrectomy ) , ) fusion ) , ) debridement ) , ) and ) ( ( vertebral ( spacer placement ) ) ( at L3-L4 ) ) ) ) ( on ( -LSB- ( ** ( 3313-12-1 ( ( ** -RSB- ) . ) ) ) ) ) ) . ) )
( Patient ( has ( no PSH ) ) )
23ec91cc-66c7-11e7-a914-f45c89b91419
neutral
He underwent partial vertebrectomy, fusion, debridement, and vertebral spacer placement at L3-L4 on [**3313-12-1**]. .
Patient has back pain
(ROOT (S (NP (PRP He)) (VP (VBD underwent) (NP (NP (JJ partial) (NN vertebrectomy)) (, ,) (NP (NN fusion)) (, ,) (NP (NN debridement)) (, ,) (CC and) (NP (NP (JJ vertebral) (NN spacer) (NN placement)) (PP (IN at) (NP (NN L3-L4))))) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 3313-12-1) (FRAG (X (SYM **)) (-RRB- -RSB-) (. .))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (ADVP (RB back)) (NP (NN pain)))))
( He ( ( ( underwent ( ( ( ( ( ( ( ( partial vertebrectomy ) , ) fusion ) , ) debridement ) , ) and ) ( ( vertebral ( spacer placement ) ) ( at L3-L4 ) ) ) ) ( on ( -LSB- ( ** ( 3313-12-1 ( ( ** -RSB- ) . ) ) ) ) ) ) . ) )
( Patient ( ( has back ) pain ) )
23ec93fe-66c7-11e7-84e8-f45c89b91419
entailment
-Colon CA: T3N2, dx 2 yrs ago, s/p resection ([**5-17**] LN+), mets to liver and brain, last CEA 7.4 -Chemo: last [**11-12**] -HTN -GERD
The patient has cancer
(ROOT (X (: -) (S (VP (NN Colon) (NP (NNP CA) (: :) (UCP (ADVP (NP (NN T3N2) (, ,) (NN dx) (CD 2) (NNS yrs)) (RB ago)) (, ,) (NP (NP (JJ s/p) (NN resection)) (PRN (-LRB- -LRB-) (INTJ (-LRB- -LSB-) (FRAG (NP (NP (NP (NP (SYM **) (CD 5-17) (X (SYM **)) (-RRB- -RSB-) (NN LN)) (CC +) (-RRB- -RRB-)) (, ,) (NP (NP (NNS mets)) (PP (TO to) (NP (NP (NN liver)) (CC and) (NP (NN brain))))) (, ,) (NP (JJ last) (NNP CEA) (CD 7.4)) (: -) (NP (NNP Chemo)) (: :)) (JJ last) (-LRB- -LSB-) (SYM **) (CD 11-12) (X (SYM **)) (FRAG (-RRB- -RSB-) (: -) (FRAG (SYM HTN) (: -) (NP (NN GERD)))))))))))))))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NN cancer)))))
( - ( Colon ( ( CA : ) ( ( ( T3N2 ( , ( dx ( 2 yrs ) ) ) ) ago ) ( , ( ( s/p resection ) ( -LRB- ( -LSB- ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ** ( 5-17 ( ** ( -RSB- LN ) ) ) ) + ) -RRB- ) , ) ( mets ( to ( ( liver and ) brain ) ) ) ) , ) ( last ( CEA 7.4 ) ) ) - ) Chemo ) : ) last ) -LSB- ) ** ) 11-12 ) ** ) ( -RSB- ( - ( HTN ( - GERD ) ) ) ) ) ) ) ) ) ) ) ) )
( ( The patient ) ( has cancer ) )
23ec962e-66c7-11e7-838f-f45c89b91419
contradiction
-Colon CA: T3N2, dx 2 yrs ago, s/p resection ([**5-17**] LN+), mets to liver and brain, last CEA 7.4 -Chemo: last [**11-12**] -HTN -GERD
The patient has no history of cancer
(ROOT (X (: -) (S (VP (NN Colon) (NP (NNP CA) (: :) (UCP (ADVP (NP (NN T3N2) (, ,) (NN dx) (CD 2) (NNS yrs)) (RB ago)) (, ,) (NP (NP (JJ s/p) (NN resection)) (PRN (-LRB- -LRB-) (INTJ (-LRB- -LSB-) (FRAG (NP (NP (NP (NP (SYM **) (CD 5-17) (X (SYM **)) (-RRB- -RSB-) (NN LN)) (CC +) (-RRB- -RRB-)) (, ,) (NP (NP (NNS mets)) (PP (TO to) (NP (NP (NN liver)) (CC and) (NP (NN brain))))) (, ,) (NP (JJ last) (NNP CEA) (CD 7.4)) (: -) (NP (NNP Chemo)) (: :)) (JJ last) (-LRB- -LSB-) (SYM **) (CD 11-12) (X (SYM **)) (FRAG (-RRB- -RSB-) (: -) (FRAG (SYM HTN) (: -) (NP (NN GERD)))))))))))))))
(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (NN cancer)))))))
( - ( Colon ( ( CA : ) ( ( ( T3N2 ( , ( dx ( 2 yrs ) ) ) ) ago ) ( , ( ( s/p resection ) ( -LRB- ( -LSB- ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ** ( 5-17 ( ** ( -RSB- LN ) ) ) ) + ) -RRB- ) , ) ( mets ( to ( ( liver and ) brain ) ) ) ) , ) ( last ( CEA 7.4 ) ) ) - ) Chemo ) : ) last ) -LSB- ) ** ) 11-12 ) ** ) ( -RSB- ( - ( HTN ( - GERD ) ) ) ) ) ) ) ) ) ) ) ) )
( ( The patient ) ( has ( ( no history ) ( of cancer ) ) ) )
23ec98ec-66c7-11e7-8971-f45c89b91419
neutral
-Colon CA: T3N2, dx 2 yrs ago, s/p resection ([**5-17**] LN+), mets to liver and brain, last CEA 7.4 -Chemo: last [**11-12**] -HTN -GERD
History of melena
(ROOT (X (: -) (S (VP (NN Colon) (NP (NNP CA) (: :) (UCP (ADVP (NP (NN T3N2) (, ,) (NN dx) (CD 2) (NNS yrs)) (RB ago)) (, ,) (NP (NP (JJ s/p) (NN resection)) (PRN (-LRB- -LRB-) (INTJ (-LRB- -LSB-) (FRAG (NP (NP (NP (NP (SYM **) (CD 5-17) (X (SYM **)) (-RRB- -RSB-) (NN LN)) (CC +) (-RRB- -RRB-)) (, ,) (NP (NP (NNS mets)) (PP (TO to) (NP (NP (NN liver)) (CC and) (NP (NN brain))))) (, ,) (NP (JJ last) (NNP CEA) (CD 7.4)) (: -) (NP (NNP Chemo)) (: :)) (JJ last) (-LRB- -LSB-) (SYM **) (CD 11-12) (X (SYM **)) (FRAG (-RRB- -RSB-) (: -) (FRAG (SYM HTN) (: -) (NP (NN GERD)))))))))))))))
(ROOT (NP (NP (NN History)) (PP (IN of) (NP (NN melena)))))
( - ( Colon ( ( CA : ) ( ( ( T3N2 ( , ( dx ( 2 yrs ) ) ) ) ago ) ( , ( ( s/p resection ) ( -LRB- ( -LSB- ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ** ( 5-17 ( ** ( -RSB- LN ) ) ) ) + ) -RRB- ) , ) ( mets ( to ( ( liver and ) brain ) ) ) ) , ) ( last ( CEA 7.4 ) ) ) - ) Chemo ) : ) last ) -LSB- ) ** ) 11-12 ) ** ) ( -RSB- ( - ( HTN ( - GERD ) ) ) ) ) ) ) ) ) ) ) ) )
( History ( of melena ) )
23ec9ac0-66c7-11e7-9e7c-f45c89b91419
entailment
Came to ED complaining of vomiting and weakness.
Patient has upper GI pain
(ROOT (NP (NP (NP (NNP Came)) (PP (TO to) (NP (NP (NNP ED)) (VP (VBG complaining) (PP (IN of) (NP (VBG vomiting) (CC and) (NP (NN weakness)))))))) (. .)))
(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ upper) (NN GI) (NN pain)))))
( ( Came ( to ( ED ( complaining ( of ( ( vomiting and ) weakness ) ) ) ) ) ) . )
( Patient ( has ( upper ( GI pain ) ) ) )